KR101574704B1 - Novel compounds, organic light emitting device display and organic solar battery using the same - Google Patents

Novel compounds, organic light emitting device display and organic solar battery using the same Download PDF

Info

Publication number
KR101574704B1
KR101574704B1 KR1020130092850A KR20130092850A KR101574704B1 KR 101574704 B1 KR101574704 B1 KR 101574704B1 KR 1020130092850 A KR1020130092850 A KR 1020130092850A KR 20130092850 A KR20130092850 A KR 20130092850A KR 101574704 B1 KR101574704 B1 KR 101574704B1
Authority
KR
South Korea
Prior art keywords
substituted
unsubstituted
compound
formula
alkyl
Prior art date
Application number
KR1020130092850A
Other languages
Korean (ko)
Other versions
KR20140021969A (en
Inventor
이경은
최진석
안용훈
김우삼
이유석
이주동
김동준
노영석
Original Assignee
희성소재 (주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 희성소재 (주) filed Critical 희성소재 (주)
Publication of KR20140021969A publication Critical patent/KR20140021969A/en
Application granted granted Critical
Publication of KR101574704B1 publication Critical patent/KR101574704B1/en

Links

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/62Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with more than three condensed rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • H10K50/171Electron injection layers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

본 발명은 하기 화학식 1로 표시되는 화합물, 이를 포함하는 유기전계발광소자 및 유기태양전지에 관한 것이다.

Figure 112013070990148-pat00130

상기 화학식 1에서, R1 내지 R6, Ar1, A, X 및 n은 명세서에서 정의한 바와 같다. The present invention relates to a compound represented by the following general formula (1), an organic electroluminescent device including the same, and an organic solar cell.
Figure 112013070990148-pat00130

In Formula 1, R 1 to R 6 , Ar 1 , A, X and n are as defined in the specification.

Description

신규한 화합물, 이를 포함하는 유기전계발광소자 및 유기태양전지{NOVEL COMPOUNDS, ORGANIC LIGHT EMITTING DEVICE DISPLAY AND ORGANIC SOLAR BATTERY USING THE SAME}TECHNICAL FIELD [0001] The present invention relates to a novel compound, an organic electroluminescent device including the same, and an organic solar cell comprising the same. BACKGROUND OF THE INVENTION [0002]

본 발명은 신규한 화합물, 이를 포함하는 유기전계발광소자 및 유기태양전지에 관한 것이다. The present invention relates to a novel compound, an organic electroluminescent device including the same, and an organic solar cell.

최근에 고효율, 장수명 유기전계발광소자의 개발이 시급한 과제로 대두되고 있다. 특히, 중대형 유기전계발광소자 패널에서 요구하고 있는 특성 수준을 고려해 볼 때, 종래의 발광 재료에 비해 매우 우수한 재료의 개발이 시급한 실정이다. 따라서, 고효율 장수명의 RGB 발광재료의 개발이 유기전계발광소자 전체의 특성을 향상시키는데 중요한 과제라고 할 수 있다.Recently, development of a high-efficiency, long-life organic electroluminescent device has become an urgent task. Particularly, in consideration of the level of characteristics required for the middle- or large-sized organic electroluminescent device panel, it is urgent to develop a material that is superior to the conventional light-emitting material. Therefore, development of a high-efficiency, long-life RGB light emitting material is an important task for improving the characteristics of the entire organic electroluminescent device.

한편, 풀칼라 유기전계발광소자 특성이 가장 우수한 소자 구조로는 호스트에 도펀트를 도핑하여 발광층을 만드는 것으로 알려져 있다. 따라서, 호스트 재료의 개발이 해결해야 할 가장 중요한 요소 중의 하나이다. 왜냐하면, 호스트 재료는 고체 상태의 용매와 에너지 전달자의 역할을 하기 때문이다. 이러한 호스트 재료는 순도가 높고 진공증착이 가능하도록 적당한 분자량을 갖는 것이 바람직하다. 또한, 호스트 재료는 유리전이온도와 열분해온도가 높아 열적 안정성이 확보되어야 한다. 또한, 호스트 재료는 장수명화를 위해 높은 전기화학적 안정성이 요구된다. 또한, 호스트 재료는 무정형 박막을 형성하기 용이해야 하며, 인접한 다른 층의 재료들과는 접착력이 좋은 반면, 층간 이동은 하지 않아야 한다.On the other hand, it is known that a device structure having the best characteristics of a full-color organic electroluminescent device is doped with a host to make a light emitting layer. Therefore, the development of the host material is one of the most important factors to be solved. This is because the host material serves as a solid state solvent and energy transfer agent. Such a host material is preferably high in purity and has a suitable molecular weight to enable vacuum deposition. In addition, the host material should have high glass transition temperature and high thermal decomposition temperature to ensure thermal stability. In addition, the host material requires high electrochemical stability for long life. Further, the host material should be easy to form an amorphous thin film, and have good adhesion to the materials of adjacent layers, but not interlayer migration.

최근에는 유기전계발광소자의 발광층으로 호스트 물질에 형광 또는 인광물질을 도펀트로서 도핑한 시스템이 활발히 연구되고 있다. 이와 같은 호스트-도펀트 시스템의 발광층은 하전입자(전자 및 정공)의 흐름을 용이하게 하여 발광소자의 구동전압을 낮출 수 있다는 장점이 있다.Recently, a system in which a host material is doped with a fluorescent material or a phosphorescent dopant as a light emitting layer of an organic electroluminescent device has been actively studied. The light emitting layer of the host-dopant system facilitates the flow of charge carriers (electrons and holes), thereby lowering the driving voltage of the light emitting device.

예를 들어, 종래의 청색 재료의 경우, 이데미쓰-고산의 디페닐비닐-비페닐(DPVBi, 하기 화학식 a로 표시되는 화합물) 이후로 많은 재료가 개발되어 상업화되어 있다. 예를 들면, 이데미쓰-고산의 청색 재료 시스템과 코닥의 디나프틸안트라센(dinaphthylanthracen; DNA, 하기 화학식 b로 표시되는 화합물)의 시스템 등이 알려져 있다. 그러나, 아직도 많은 연구 개발이 이루어져야 할 것으로 판단된다. 왜냐하면, 현재까지 가장 효율이 좋다고 알려진 이데미쓰-고산의 디스트릴(distryl) 화합물의 시스템은 전력 효율의 경우, 6㏐/W이고 소자 수명이 30,000시간 이상으로 좋긴 하지만, 구동 시간에 따른 색순도의 저하로 인하여 풀칼라 디스플레이에 적용했을 때, 수명이 불과 수천 시간에 불과하기 때문이다. 그리고, 청색 발광은 발광 파장이 장파장 쪽으로 조금만 이동해도 발광 효율 측면에서는 유리해지나, 순청색을 만족시키지 못해 고품위의 디스플레이에는 적용이 쉽지 않고, 색순도, 효율 및 열안정성에 문제가 있어 연구 개발이 시급하다.For example, in the case of a conventional blue material, many materials have been developed and commercialized since diphenylvinyl-biphenyl (DPVBi, a compound represented by the following formula a) of Idemitsu-Gosan. For example, a blue material system of Idemitsu-Gosan and a system of dinaphthylanthracene (DNA, a compound represented by the following formula b) of Kodak and the like are known. However, a lot of research and development is still required. This is because the distill compound system of Idemitsu-Gosan, which is known to be the most efficient to date, has a power consumption of 6 kW / W and a device lifetime of 30,000 hours or more. However, Due to the fact that when applied to a full color display, the lifetime is only a few thousand hours. Further, the blue light emission is advantageous in light emission efficiency even if the emission wavelength shifts a little toward the long wavelength side, but it can not satisfy the pure blue light, so it is not easy to apply to a high quality display, and there is a problem in color purity, efficiency and thermal stability. .

Figure 112013070990148-pat00001
Figure 112013070990148-pat00001

또한, 경상대와 삼성 SDI에서 발표한 TBSA[Kwon, S. K. et. al. Advanced Materials, 2001, 13, 1690; JP2002-121547A]의 경우, 7.7V에서 3㏅/A 의 발광효율과 (0.15, 0.11)의 비교적 좋은 색좌표를 보였으나 단일층의 재료로 적용되었을 때, 상용화 수준에는 미흡한 것으로 알려져 있다. 또한, 국립대만대에서 발표한 TSF[Wu, C. -C., et. al. Advanced Materials, 2004, 16, 61; US2005-0074631A]의 경우 비교적 우수한 5.3%의 외부 양자효율을 보였으나, 역시 상용화 수준에는 역시 미흡하다. 또한, 대만의 칭화국립대에서 발표한 BTP의 경우[Cheng, C. -H, et. al. Advanced Materials, 2002, 14, 1409; US2004-0076852A] 2.76 ㏅/A의 발광효율과 (0.16, 0.14)의 비교적 좋은 색좌표를 보였으나 상용화 수준에는 미흡하다. In addition, TBSA [Kwon, S. K. et. al. Advanced Materials, 2001, 13, 1690; JP2002-121547A] showed relatively good color coordinates of (0.15, 0.11) and a luminous efficiency of 3 keV / A at 7.7 V, but it is known to be insufficient in commercialization level when applied as a single layer material. In addition, TSF [Wu, C. -C., et. al. Advanced Materials, 2004, 16, 61; US2005-0074631A] exhibits a relatively excellent external quantum efficiency of 5.3%, but it is also insufficient for commercialization level. In the case of BTP published by Tsinghua National University in Taiwan [Cheng, C. -H, et. al. Advanced Materials, 2002, 14, 1409; US2004-0076852A] showed a good color coordinate of 2.76 ㏅ / A and a good color coordinate of (0.16, 0.14), but it is insufficient in commercialization level.

이와 같이, 종래의 재료들은 호스트-도펀트 박막층을 구성하지 않고 단일층으로 구성되어 있으며, 색순도 및 효율 측면에서 상용화가 어려운 것으로 판단되며, 장수명에 대한 신뢰성 있는 데이터도 미비한 상황이다.As described above, conventional materials do not constitute a host-dopant thin film layer and are composed of a single layer. It is considered that commercialization is difficult in terms of color purity and efficiency, and reliable data on long life is insufficient.

한편, 일본의 미쯔이 화학의 US2005-0074631A에 의하면 하기 화합물들이 4.6㏅/A의 발광효율을 보이는 것으로 확인되었다.On the other hand, according to US2005-0074631A of Mitsui Chemicals, Japan, the following compounds were found to exhibit luminous efficiency of 4.6 kPa / A.

Figure 112013070990148-pat00002
Figure 112013070990148-pat00002

그러나, 이 화합물들의 경우, 청록색(bluish green color)으로 명시하고 있다. 특히, 상기와 같은 대칭적 구조에서는 순청색의 구현이 불가능하며, 이러한 순청색의 발광을 갖지 못하는 재료로는 풀칼라용 디스플레이 적용을 위한 상용화에는 미흡하다고 판단된다.However, these compounds are designated as bluish green color. Particularly, it is impossible to realize a pure blue color in the symmetrical structure as described above, and it is considered to be insufficient for commercialization for a full color display application as a material which does not have such a pure blue light emission.

상기 선행기술에 개시된 유기 발광 화합물들은 열안정성이 낮이 이를 이용하여 제조된 발광소자의 수명이 길지 않다는 문제점이 계속되고 있다. 이에, 본 발명자들은 안트라센과 그에 치환된 측쇄기를 링으로 형성시켜 발광 화합물의 열안정성을 향상시키고 이를 유기발광소자에 적용하는 경우. 종래의 발광물질을 적용하는 경우에 비하여 현저하게 유기발광소자의 수명 및 효율, 색 순도가 높아 질 수 될 수 있음을 확인하고 본 발명을 완성하였다.The organic luminescent compounds disclosed in the prior art have low thermal stability and the lifetime of the light emitting device manufactured using the organic luminescent compound is not long. Accordingly, the present inventors have found that when anthracene and its substituted side chain groups are formed as rings to improve the thermal stability of a light emitting compound and applied to an organic light emitting device. The life, efficiency and color purity of the organic light emitting device can be significantly increased as compared with the case of applying the conventional light emitting material. Thus, the present invention has been completed.

본 발명의 목적은 열안정성이 뛰어나고 색순도가 우수한 화합물을 제공하는 것이다. 보다 상세하게 설명하면, 본 발명의 목적은 안트라센과 그에 치환된 측쇄기를 고리로 형성시킴으로써, 안트라센 골격과 측쇄기의 구조가 평면을 유지시켜 분자간 결합을 매우 높여 열안정성이 뛰어나고 발광효율 및 수명이 우수한 유기화합물을 제공하는 것이다.It is an object of the present invention to provide a compound excellent in thermal stability and excellent in color purity. More specifically, it is an object of the present invention to provide an anthracene compound having an anthracene skeleton and a side chain group in which an anthracene skeleton and a side chain group are maintained in a planar state by forming an anthracene and a substituted side chain group thereof in a ring, Thereby providing an organic compound.

또한, 본 발명의 목적은 발광효율 및 수명이 우수한 유기전계발광소자 및 유기태양전지를 제공하는 것이다.It is another object of the present invention to provide an organic electroluminescent device and an organic solar cell excellent in luminous efficiency and lifetime.

본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다;The present invention provides a compound represented by the following formula (1);

Figure 112013070990148-pat00003
Figure 112013070990148-pat00003

상기 화학식 1에서,In Formula 1,

R1 내지 R6은 서로 같거나 다르고, 각각 독립적으로, 수소; 할로겐 원자; 아다만틸; 나이트로; 하이드록시; 시아노; 치환 또는 비치환된 (C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴; 치환 또는 비치환된 (C5-C60)헤테로아릴; N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬; 치환 또는 비치환된 (C3-C60)시클로알킬; 치환 또는 비치환된 트리(C1-C60)알킬실릴; 치환 또는 비치환된 디(C1-C60)알킬(C6-C60)아릴실릴; 치환 또는 비치환된 트리(C6-C60)아릴실릴; 치환 또는 비치환된 (C7-C60)바이시클로알킬; 치환 또는 비치환된 (C2-C60)알케닐; 치환 또는 비치환된 (C2-C60 )알키닐; 치환 또는 비치환된 (C1-C60)알콕시; 치환 또는 비치환된 (C1-C60)알킬아미노; 치환 또는 비치환된 (C6-C60)아릴아미노; 치환 또는 비치환된 (C6-C60)아르(C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴옥시; 치환 또는 비치환된 (C6-C60)아릴티오; 치환 또는 비치환된 (C1-C60)알킬티오; 치환 또는 비치환된 (C1-C60)알콕시카보닐; 치환 또는 비치환된 (C1-C60)알킬카보닐; 또는 (C6-C60)아릴카보닐이며, 상기 R1 내지 R6는 인접하는 기와 서로 결합하여 지방족 고리, 방향족 고리, 헤테로 방향족 고리를 형성하거나, 치환 또는 비치환된 (C2-C60)알킬렌 또는 (C2-C60)알케닐렌으로 서로 연결하여 지방족 고리, 방향족 고리, 헤테로 방향족 고리를 형성하고,R 1 to R 6 are the same or different from each other and each independently hydrogen; A halogen atom; Adamantyl; Nitro; Hydroxy; Cyano; Substituted or unsubstituted (C 1 -C 60 ) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryl; Substituted or unsubstituted (C 5 -C 60) heteroaryl; 5 or 6-membered heterocycloalkyl containing one or more heteroatoms selected from N, O, S and Si; Substituted or unsubstituted (C 3 -C 60 ) cycloalkyl; A substituted or unsubstituted tree (C 1 -C 60) alkylsilyl; A substituted or unsubstituted di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl; A substituted or unsubstituted tree (C 6 -C 60) arylsilyl; Substituted or unsubstituted (C 7 -C 60) bicycloalkyl-alkyl; Substituted or unsubstituted (C 2 -C 60 ) alkenyl; Substituted or unsubstituted (C 2 -C 60 ) alkynyl; Substituted or unsubstituted (C 1 -C 60) alkoxy; Substituted or unsubstituted (C 1 -C 60 ) alkylamino; Substituted or unsubstituted (C 6 -C 60 ) arylamino; Substituted or unsubstituted (C 6 -C 60) aralkyl (C 1 -C 60) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryloxy; Substituted or unsubstituted (C 6 -C 60 ) arylthio; A substituted or unsubstituted (C 1 -C 60) alkylthio; Substituted or unsubstituted (C 1 -C 60 ) alkoxycarbonyl; Substituted or unsubstituted (C 1 -C 60) alkylcarbonyl; Or (C 6 -C 60 ) arylcarbonyl, wherein R 1 to R 6 are bonded to adjacent groups to form an aliphatic ring, an aromatic ring, a heteroaromatic ring, or a substituted or unsubstituted (C 2 -C 60) ) alkylene or (C 2 -C 60) connected to each other in the alkenylene to form an aliphatic ring, an aromatic ring, a heteroaromatic ring,

Ar1은 1∼5개의 고리를 갖는 치환 또는 비치환된 (C6-C60)의 방향족 화합물 또는 융합고리형 방향족 화합물이고, Ar 1 is a substituted or unsubstituted (C 6 -C 60 ) aromatic compound having 1 to 5 rings or a fused ring aromatic compound,

A는 아다만틸; 나이트로; 하이드록시; 시아노; 치환 또는 비치환된 (C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴; 치환 또는 비치환된 (C2-C60)헤테로아릴; N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬; 치환 또는 비치환된 (C3-C60)시클로알킬; 치환 또는 비치환된 트리(C1-C60)알킬실릴; 치환 또는 비치환된 디(C1-C60)알킬(C6-C60)아릴실릴; 치환 또는 비치환된 트리(C6-C60)아릴실릴; 치환 또는 비치환된 (C7-C60)바이시클로알킬; 치환 또는 비치환된 (C2-C60)알케닐; 치환 또는 비치환된 (C2-C60)알키닐; 치환 또는 비치환된 (C1-C60)알콕시; 치환 또는 비치환된 (C1-C60)알킬아미노; 치환 또는 비치환된 (C6-C60)아릴아미노; 치환 또는 비치환된 (C6-C60)아르(C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴옥시; 치환 또는 비치환된 (C6-C60)아릴티오; 치환 또는 비치환된 (C1-C60)알킬티오; 치환 또는 비치환된 (C1-C60)알콕시카보닐; 치환 또는 비치환된 (C1-C60)알킬카보닐; (C6-C60)아릴카보닐; 또는

Figure 112013070990148-pat00004
이되,A is adamantyl; Nitro; Hydroxy; Cyano; Substituted or unsubstituted (C 1 -C 60 ) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryl; Substituted or unsubstituted (C 2 -C 60 ) heteroaryl; 5 or 6-membered heterocycloalkyl containing one or more heteroatoms selected from N, O, S and Si; Substituted or unsubstituted (C 3 -C 60 ) cycloalkyl; A substituted or unsubstituted tree (C 1 -C 60) alkylsilyl; A substituted or unsubstituted di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl; A substituted or unsubstituted tree (C 6 -C 60) arylsilyl; Substituted or unsubstituted (C 7 -C 60) bicycloalkyl-alkyl; Substituted or unsubstituted (C 2 -C 60 ) alkenyl; Substituted or unsubstituted (C 2 -C 60 ) alkynyl; Substituted or unsubstituted (C 1 -C 60) alkoxy; Substituted or unsubstituted (C 1 -C 60 ) alkylamino; Substituted or unsubstituted (C 6 -C 60 ) arylamino; Substituted or unsubstituted (C 6 -C 60) aralkyl (C 1 -C 60) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryloxy; Substituted or unsubstituted (C 6 -C 60 ) arylthio; A substituted or unsubstituted (C 1 -C 60) alkylthio; Substituted or unsubstituted (C 1 -C 60 ) alkoxycarbonyl; Substituted or unsubstituted (C 1 -C 60) alkylcarbonyl; (C 6 -C 60 ) arylcarbonyl; or
Figure 112013070990148-pat00004
However,

Ar3는 치환 또는 비치환된 (C1-C60)알킬렌옥시; 치환 또는 비치환된 (C1-C60)알킬렌티오; 치환 또는 비치환된 (C6-C60)아릴렌옥시; (C6-C60)아릴렌티오; 치환 또는 비치환된 (C6-C60)아릴렌; 또는 (C3-C60)헤테로아릴렌이고,Ar 3 is substituted or unsubstituted (C 1 -C 60 ) alkyleneoxy; Substituted or unsubstituted (C 1 -C 60) alkylene-thio; Substituted or unsubstituted (C 6 -C 60 ) aryleneoxy; (C 6 -C 60 ) arylene thio; Substituted or unsubstituted (C 6 -C 60 ) arylene; Or (C 3 -C 60) and heteroarylene,

R7은 R1 내지 R6의 기재와 동일하고,R 7 is the same as the description of R 1 to R 6 ,

n은 0 내지 3이고,n is from 0 to 3,

n이 0이 아닐 경우, X는 -O-, -Si(-R21)(-R22)-, -N(-R21)- 또는 -C(-R21)(-R22)-로서, If n is not a 0, X is -O-, -Si (-R 21) ( - R 22) -, -N (-R 21) - or -C (-R 21) (- R 22) - a ,

이때, R21 및 R22는 각각 독립적으로 수소; 직쇄상 또는 분지상의 (C1-C60)알킬; (C6-C60)아릴; (C6-C60)알콕시아릴; (C1-C60)알킬티오(C6-C60)아릴; 또는 아미노(C6-C60)아릴, (C1-C60)알킬실릴(C6-C60)아릴이고, Wherein R 21 and R 22 are each independently selected from the group consisting of hydrogen; Straight or branched (C 1 -C 60) alkyl; (C 6 -C 60 ) aryl; (C 6 -C 60 ) alkoxyaryl; (C 1 -C 60) alkylthio (C 6 -C 60) aryl; (C 6 -C 60 ) aryl, (C 1 -C 60 ) alkylsilyl (C 6 -C 60 ) aryl,

상기 R1 내지 R6, Ar1, A 및 Ar3에서의 치환은 서로 같거나 다르고, 각각 독립적으로, 할로겐, (C1-C60)알킬, (C6-C60)아릴, (C2-C60)헤테로아릴, N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬, (C3-C60)시클로알킬, 트리(C1-C60)알킬실릴, 디(C1-C60)알킬(C6-C60)아릴실릴, 트리(C6-C60)아릴실릴, 아다만틸, (C7-C60)바이시클로알킬, (C2-C60)알케닐, (C2-C60)알키닐, (C1-C60)알콕시, 시아노, (C1-C60)알킬아미노, (C6-C60)아릴아미노, (C6-C60)아르(C1-C60)알킬, (C6-C60)아릴옥시, (C1-C60)알킬티오, (C6-C60)아릴티오, (C1-C60)알콕시카보닐, (C1-C60)알킬카보닐, (C6-C60)아릴카보닐, 카복실산, 나이트로 또는 하이드록시로 치환될 수 있다. Wherein R 1 to R 6, Ar 1, and Ar 3 is A substitution at the same or different, each independently, halogen, (C 1 -C 60) alkyl, (C 6 -C 60) aryl, (C 2 -C 60) heteroaryl, N, O, S, and 5-or 6-membered heterocycloalkyl containing one or two or more selected from Si, (C 3 -C 60) cycloalkyl, tri (C 1 - C 60) alkylsilyl, di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl, tri (C 6 -C 60) arylsilyl, adamantyl, (C 7 -C 60) alkyl bicyclo , (C 2 -C 60) alkenyl, (C 2 -C 60) alkynyl, (C 1 -C 60) alkoxy, cyano, (C 1 -C 60) alkylamino, (C 6 -C 60) arylamino, (C 6 -C 60) aralkyl (C 1 -C 60) alkyl, (C 6 -C 60) aryloxy, (C 1 -C 60) alkylthio, (C 6 -C 60) arylthio, (C 1 -C 60 ) alkoxycarbonyl, (C 1 -C 60 ) alkylcarbonyl, (C 6 -C 60 ) arylcarbonyl, carboxylic acid, nitro or hydroxy.

본 발명은 제 1 전극; 제 2 전극; 및 상기 제 1 전극과 제 2 전극 사이에 위치하고, 상기 화학식 1로 표시되는 화합물을 포함하는 유기막을 포함하는 것을 특징으로 하는 유기전계발광소자를 제공한다.The present invention relates to a plasma display panel comprising a first electrode; A second electrode; And an organic layer disposed between the first electrode and the second electrode and including a compound represented by Formula 1.

본 발명은 제 1 전극; 제 2 전극; 및 상기 제 1 전극과 제 2 전극 사이에 위치하고 상기 화학식 1로 표시되는 화합물을 포함하는 유기막을 포함하는 것을 특징으로 하는 유기태양전지를 제공한다.The present invention relates to a plasma display panel comprising a first electrode; A second electrode; And an organic layer disposed between the first electrode and the second electrode and including a compound represented by Formula 1.

본 발명의 화합물은 열안정성이 뛰어나므로 유기전계발광소자에 적용했을 때, 수명이 길고, 발광효율 및 색좌표가 우수하다. 본 발명의 화합물은 적색, 녹색, 청색의 형광 및 인광의 유기전계발광소자의 유기막층 재료에 적합하다. 특히, 본 발명의 화합물은 정공수송층의 청색 형광용 재료로 적합하다. 본 발명의 유기전계발광소자는 수명이 길고 발광효율이 우수하고, 색순도가 높다.Since the compound of the present invention is excellent in thermal stability, it has a long lifetime when applied to an organic electroluminescent device, and is excellent in luminous efficiency and color coordinates. The compound of the present invention is suitable for an organic film layer material of an organic electroluminescence device of red, green and blue fluorescence and phosphorescence. Particularly, the compound of the present invention is suitable as a blue fluorescent material for a hole transport layer. The organic electroluminescent device of the present invention has a long lifetime, excellent luminous efficiency, and high color purity.

이하에서, 본 발명의 상세한 이해를 위하여 본 발명의 대표 화합물을 예를 들어 본 발명에 따른 화합물, 이의 제조방법 및 유기전계발광소자를 설명하나, 이는 단지 그 실시 양태를 예시하기 위한 것일 뿐, 본 발명의 범위를 한정하는 것은 아니다.
Hereinafter, for a detailed understanding of the present invention, a representative compound of the present invention will be described, for example, a compound according to the present invention, a method for producing the same, and an organic electroluminescent device. However, And are not intended to limit the scope of the invention.

Ⅰ. 화합물Ⅰ. compound

본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.The present invention provides a compound represented by the following formula (1).

Figure 112013070990148-pat00005
Figure 112013070990148-pat00005

상기 화학식 1에서,In Formula 1,

R1 내지 R6은 서로 같거나 다르고, 각각 독립적으로, 수소; 할로겐 원자; 아다만틸; 나이트로; 하이드록시; 시아노; 치환 또는 비치환된 (C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴; 치환 또는 비치환된 (C5-C60)헤테로아릴; N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬; 치환 또는 비치환된 (C3-C60)시클로알킬; 치환 또는 비치환된 트리(C1-C60)알킬실릴; 치환 또는 비치환된 디(C1-C60)알킬(C6-C60)아릴실릴; 치환 또는 비치환된 트리(C6-C60)아릴실릴; 치환 또는 비치환된 (C7-C60)바이시클로알킬; 치환 또는 비치환된 (C2-C60)알케닐; 치환 또는 비치환된 (C2-C60 )알키닐; 치환 또는 비치환된 (C1-C60)알콕시; 치환 또는 비치환된 (C1-C60)알킬아미노; 치환 또는 비치환된 (C6-C60)아릴아미노; 치환 또는 비치환된 (C6-C60)아르(C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴옥시; 치환 또는 비치환된 (C6-C60)아릴티오; 치환 또는 비치환된 (C1-C60)알킬티오; 치환 또는 비치환된 (C1-C60)알콕시카보닐; 치환 또는 비치환된 (C1-C60)알킬카보닐; 또는 (C6-C60)아릴카보닐이며, 상기 R1 내지 R6는 인접하는 기와 서로 결합하여 지방족 고리, 방향족 고리, 헤테로 방향족 고리를 형성하거나, 치환 또는 비치환된 (C2-C60)알킬렌 또는 (C2-C60)알케닐렌으로 서로 연결하여 지방족 고리, 방향족 고리, 헤테로 방향족 고리를 형성하고,R 1 to R 6 are the same or different from each other and each independently hydrogen; A halogen atom; Adamantyl; Nitro; Hydroxy; Cyano; Substituted or unsubstituted (C 1 -C 60 ) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryl; Substituted or unsubstituted (C 5 -C 60) heteroaryl; 5 or 6-membered heterocycloalkyl containing one or more heteroatoms selected from N, O, S and Si; Substituted or unsubstituted (C 3 -C 60 ) cycloalkyl; A substituted or unsubstituted tree (C 1 -C 60) alkylsilyl; A substituted or unsubstituted di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl; A substituted or unsubstituted tree (C 6 -C 60) arylsilyl; Substituted or unsubstituted (C 7 -C 60) bicycloalkyl-alkyl; Substituted or unsubstituted (C 2 -C 60 ) alkenyl; Substituted or unsubstituted (C 2 -C 60 ) alkynyl; Substituted or unsubstituted (C 1 -C 60) alkoxy; Substituted or unsubstituted (C 1 -C 60 ) alkylamino; Substituted or unsubstituted (C 6 -C 60 ) arylamino; Substituted or unsubstituted (C 6 -C 60) aralkyl (C 1 -C 60) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryloxy; Substituted or unsubstituted (C 6 -C 60 ) arylthio; A substituted or unsubstituted (C 1 -C 60) alkylthio; Substituted or unsubstituted (C 1 -C 60 ) alkoxycarbonyl; Substituted or unsubstituted (C 1 -C 60) alkylcarbonyl; Or (C 6 -C 60 ) arylcarbonyl, wherein R 1 to R 6 are bonded to adjacent groups to form an aliphatic ring, an aromatic ring, a heteroaromatic ring, or a substituted or unsubstituted (C 2 -C 60) ) alkylene or (C 2 -C 60) connected to each other in the alkenylene to form an aliphatic ring, an aromatic ring, a heteroaromatic ring,

Ar1은 1∼5개의 고리를 갖는 치환 또는 비치환된 (C6-C60)의 방향족 화합물 또는 융합고리형 방향족 화합물이고, Ar 1 is a substituted or unsubstituted (C 6 -C 60 ) aromatic compound having 1 to 5 rings or a fused ring aromatic compound,

A는 아다만틸; 나이트로; 하이드록시; 시아노; 치환 또는 비치환된 (C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴; 치환 또는 비치환된 (C2-C60)헤테로아릴; N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬; 치환 또는 비치환된 (C3-C60)시클로알킬; 치환 또는 비치환된 트리(C1-C60)알킬실릴; 치환 또는 비치환된 디(C1-C60)알킬(C6-C60)아릴실릴; 치환 또는 비치환된 트리(C6-C60)아릴실릴; 치환 또는 비치환된 (C7-C60)바이시클로알킬; 치환 또는 비치환된 (C2-C60)알케닐; 치환 또는 비치환된 (C2-C60)알키닐; 치환 또는 비치환된 (C1-C60)알콕시; 치환 또는 비치환된 (C1-C60)알킬아미노; 치환 또는 비치환된 (C6-C60)아릴아미노; 치환 또는 비치환된 (C6-C60)아르(C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴옥시; 치환 또는 비치환된 (C6-C60)아릴티오; 치환 또는 비치환된 (C1-C60)알킬티오; 치환 또는 비치환된 (C1-C60)알콕시카보닐; 치환 또는 비치환된 (C1-C60)알킬카보닐; (C6-C60)아릴카보닐; 또는

Figure 112013070990148-pat00006
이되,A is adamantyl; Nitro; Hydroxy; Cyano; Substituted or unsubstituted (C 1 -C 60 ) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryl; Substituted or unsubstituted (C 2 -C 60 ) heteroaryl; 5 or 6-membered heterocycloalkyl containing one or more heteroatoms selected from N, O, S and Si; Substituted or unsubstituted (C 3 -C 60 ) cycloalkyl; A substituted or unsubstituted tree (C 1 -C 60) alkylsilyl; A substituted or unsubstituted di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl; A substituted or unsubstituted tree (C 6 -C 60) arylsilyl; Substituted or unsubstituted (C 7 -C 60) bicycloalkyl-alkyl; Substituted or unsubstituted (C 2 -C 60 ) alkenyl; Substituted or unsubstituted (C 2 -C 60 ) alkynyl; Substituted or unsubstituted (C 1 -C 60) alkoxy; Substituted or unsubstituted (C 1 -C 60 ) alkylamino; Substituted or unsubstituted (C 6 -C 60 ) arylamino; Substituted or unsubstituted (C 6 -C 60) aralkyl (C 1 -C 60) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryloxy; Substituted or unsubstituted (C 6 -C 60 ) arylthio; A substituted or unsubstituted (C 1 -C 60) alkylthio; Substituted or unsubstituted (C 1 -C 60 ) alkoxycarbonyl; Substituted or unsubstituted (C 1 -C 60) alkylcarbonyl; (C 6 -C 60 ) arylcarbonyl; or
Figure 112013070990148-pat00006
However,

Ar3는 치환 또는 비치환된 (C1-C60)알킬렌옥시; 치환 또는 비치환된 (C1-C60)알킬렌티오; 치환 또는 비치환된 (C6-C60)아릴렌옥시; (C6-C60)아릴렌티오; 치환 또는 비치환된 (C6-C60)아릴렌; 또는 (C3-C60)헤테로아릴렌이고,Ar 3 is substituted or unsubstituted (C 1 -C 60 ) alkyleneoxy; Substituted or unsubstituted (C 1 -C 60) alkylene-thio; Substituted or unsubstituted (C 6 -C 60 ) aryleneoxy; (C 6 -C 60 ) arylene thio; Substituted or unsubstituted (C 6 -C 60 ) arylene; Or (C 3 -C 60) and heteroarylene,

R7은 R1 내지 R6의 기재와 동일하고,R 7 is the same as the description of R 1 to R 6 ,

n은 0 내지 3이고,n is from 0 to 3,

n이 0이 아닐 경우, X는 -O-, -Si(-R21)(-R22)-, -N(-R21)- 또는 -C(-R21)(-R22)-로서, If n is not a 0, X is -O-, -Si (-R 21) ( - R 22) -, -N (-R 21) - or -C (-R 21) (- R 22) - a ,

이때, R21 및 R22는 각각 독립적으로 수소; 직쇄상 또는 분지상의 (C1-C60)알킬; (C6-C60)아릴; (C6-C60)알콕시아릴; (C1-C60)알킬티오(C6-C60)아릴; 또는 아미노(C6-C60)아릴, (C1-C60)알킬실릴(C6-C60)아릴이고, Wherein R 21 and R 22 are each independently selected from the group consisting of hydrogen; Straight or branched (C 1 -C 60) alkyl; (C 6 -C 60 ) aryl; (C 6 -C 60 ) alkoxyaryl; (C 1 -C 60) alkylthio (C 6 -C 60) aryl; (C 6 -C 60 ) aryl, (C 1 -C 60 ) alkylsilyl (C 6 -C 60 ) aryl,

상기 R1 내지 R6, Ar1, A 및 Ar3에서의 치환은 서로 같거나 다르고, 각각 독립적으로, 할로겐, (C1-C60)알킬, (C6-C60)아릴, (C2-C60)헤테로아릴, N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬, (C3-C60)시클로알킬, 트리(C1-C60)알킬실릴, 디(C1-C60)알킬(C6-C60)아릴실릴, 트리(C6-C60)아릴실릴, 아다만틸, (C7-C60)바이시클로알킬, (C2-C60)알케닐, (C2-C60)알키닐, (C1-C60)알콕시, 시아노, (C1-C60)알킬아미노, (C6-C60)아릴아미노, (C6-C60)아르(C1-C60)알킬, (C6-C60)아릴옥시, (C1-C60)알킬티오, (C6-C60)아릴티오, (C1-C60)알콕시카보닐, (C1-C60)알킬카보닐, (C6-C60)아릴카보닐, 카복실산, 나이트로 또는 하이드록시로 치환될 수 있다.
Wherein R 1 to R 6, Ar 1, and Ar 3 is A substitution at the same or different, each independently, halogen, (C 1 -C 60) alkyl, (C 6 -C 60) aryl, (C 2 -C 60) heteroaryl, N, O, S, and 5-or 6-membered heterocycloalkyl containing one or two or more selected from Si, (C 3 -C 60) cycloalkyl, tri (C 1 - C 60) alkylsilyl, di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl, tri (C 6 -C 60) arylsilyl, adamantyl, (C 7 -C 60) alkyl bicyclo , (C 2 -C 60) alkenyl, (C 2 -C 60) alkynyl, (C 1 -C 60) alkoxy, cyano, (C 1 -C 60) alkylamino, (C 6 -C 60) arylamino, (C 6 -C 60) aralkyl (C 1 -C 60) alkyl, (C 6 -C 60) aryloxy, (C 1 -C 60) alkylthio, (C 6 -C 60) arylthio, (C 1 -C 60 ) alkoxycarbonyl, (C 1 -C 60 ) alkylcarbonyl, (C 6 -C 60 ) arylcarbonyl, carboxylic acid, nitro or hydroxy.

상기 화학식 1로 표시되는 화합물은 하기 화학식 1A로 표시되는 화합물인 것이 바람직하다.The compound represented by Formula 1 is preferably a compound represented by Formula 1A below.

Figure 112013070990148-pat00007
Figure 112013070990148-pat00007

상기 화학식 1A에 있어서,In the above formula (1A)

R1 내지 R6은 상기 화학식 1에서 정의한 바와 같고,R 1 to R 6 are the same as defined in Formula 1,

A는 치환 또는 비치환된 (C6-C60)아릴 또는 치환 또는 비치환된 (C2-C60)헤테로 아릴이고,A is a substituted or unsubstituted (C 6 -C 60 ) aryl or a substituted or unsubstituted (C 2 -C 60 ) heteroaryl,

n은 0 내지 1이고, n is from 0 to 1,

n이 1일 경우, X는 -N(-R21)- 또는 -C(-R21)(-R22)-이고,When n is 1, X is -N (-R 21 ) - or -C (-R 21 ) (-R 22 ) -,

R21 및 R22는 상기 화학식 1에서 정의한 바와 같고,R 21 and R 22 are the same as defined in Formula 1,

R17 내지 R20은 인접하는 기끼리 서로 결합하여 1종 또는 2종 이상의 방향족 또는 지방족 환을 형성한다.The adjacent groups of R 17 to R 20 are bonded to each other to form one or more aromatic or aliphatic rings.

그리고, 상기 화학식 1로 표시되는 화합물은 하기 화학식 2 내지 화학식 13으로부터 선택되는 것이 바람직하다.The compound represented by the formula (1) is preferably selected from the following formulas (2) to (13).

<화학식 2> <화학식 3> <화학식 4>&Lt; Formula 2 > < EMI ID =

Figure 112013070990148-pat00008
Figure 112013070990148-pat00009
Figure 112013070990148-pat00010
Figure 112013070990148-pat00008
Figure 112013070990148-pat00009
Figure 112013070990148-pat00010

<화학식 5> <화학식 6> <화학식 7>&Lt; Formula 5 > < EMI ID =

Figure 112013070990148-pat00011
Figure 112013070990148-pat00012
Figure 112013070990148-pat00013
Figure 112013070990148-pat00011
Figure 112013070990148-pat00012
Figure 112013070990148-pat00013

<화학식 8> <화학식 9> <화학식 10>&Lt; Formula 8 > < EMI ID =

Figure 112013070990148-pat00014
Figure 112013070990148-pat00015
Figure 112013070990148-pat00016
Figure 112013070990148-pat00014
Figure 112013070990148-pat00015
Figure 112013070990148-pat00016

<화학식 11> <화학식 12> <화학식 13>&Lt; Formula 11 > < EMI ID =

Figure 112013070990148-pat00017
Figure 112013070990148-pat00018
Figure 112013070990148-pat00019
Figure 112013070990148-pat00017
Figure 112013070990148-pat00018
Figure 112013070990148-pat00019

상기 화학식 2 내지 화학식 13에서,In the above Chemical Formulas 2 to 13,

A, R1 내지 R6은 상기 화학식 1에서 정의한 바와 같고,A, R 1 to R 6 are the same as defined in the above formula (1)

R9 내지 R16은 각각 독립적으로, R1 내지 R6의 기재와 동일하며,R 9 to R 16 each independently represent a group selected from the group consisting of R 1 To R &lt; 6 &gt;

R21 및 R22는 각각 독립적으로 수소; 직쇄상 또는 분지상의 (C1-C60)알킬; (C6-C60)아릴; (C6-C60)알콕시아릴; (C1-C60)알킬티오(C6-C60)아릴; 아미노(C6-C60)아릴; 또는 (C1-C60)알킬실릴(C6-C60)아릴이다.R 21 and R 22 are each independently hydrogen; Straight or branched (C 1 -C 60) alkyl; (C 6 -C 60 ) aryl; (C 6 -C 60 ) alkoxyaryl; (C 1 -C 60) alkylthio (C 6 -C 60) aryl; Amino (C 6 -C 60 ) aryl; Or (C 1 -C 60 ) alkylsilyl (C 6 -C 60 ) aryl.

한편, 상기 R1 내지 R6의 구체적인 예로는, 수소, 클로로, 플루오르, 아다만틸, 카복실산, 나이트로, 하이드록시, 시아노, 메틸, 에틸, n-프로필, n-부틸, t-부틸, n-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 벤질, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 메톡시, 에톡시, n-프로폭시, i-프로폭시, n-부톡시, i-부톡시, t-부톡시, n-펜톡시, i-펜톡시, n-헥실옥시, n-헵톡시, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸, 시클로노닐, 시클로데실, 모폴리노, 티오모폴리노, 페닐, 나프틸, 비페닐, 9,9-디메틸플루오레닐, 9,9-디페닐플루오레닐, 페난트릴, 안트릴, 플루오란텐일, 트리페닐렌일, 피렌일, 크라이세닐, 나프타세닐, 페릴렌일, 스피로바이플루오레닐, 피리딜, 피롤릴, 퓨란일, 티오펜일, 이미다졸릴, 벤조이미다졸릴, 피라진일, 피리미딘일, 피리다진일, 퀴놀릴, 트리아진일, 벤조퓨란일, 벤조티오펜일, 피라졸릴, 인돌릴, 카바졸릴, 티아졸릴, 옥사졸릴, 벤조티아졸릴, 벤조옥사졸릴, 페난트롤린일, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 바이시클로[2.2.1]헵틸, 바이시클로[2.2.2]옥틸, 바이시클로[3.2.1]옥틸, 바이시클로[5.2.0]노닐, 바이시클로[4.2.2]데실, 바이시클로[2.2.2]옥틸, 4-펜틸바이시클로[2.2.2]옥틸, 에테닐, 페닐에테닐, 에티닐, 페닐에티닐, 디메틸아미노, 디페닐아미노, 모노메틸아미노, 모노페닐아미노, 페닐옥시, 페닐티오, 메톡시카보닐, 에톡시카보닐, t-부톡시카보닐, 메틸카보닐, 에틸카보닐, 벤질카보닐 또는 페닐카보닐 등을 들 수 있다. 상기 R1 내지 R6은 서로 같거나 다를 수 있고, 각각 독립적이다.Specific examples of R 1 to R 6 include hydrogen, chloro, fluoro, adamantyl, carboxylic acid, nitro, cyano, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, benzyl, trifluoromethyl, perfluoroethyl, N-propoxy, i-propoxy, n-butoxy, i-butoxy, t-butoxy, n-pentoxy, Cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, morpholino, thiomorpholino, phenyl, naphthyl, biphenyl, naphthyl, cyclopentyl, cyclohexyl, 9-dimethylfluorenyl, 9,9-diphenylfluorenyl, phenanthryl, anthryl, fluoranthenyl, triphenyleney, pyryl, klycenyl, naphthacenyl, Wherein R is selected from the group consisting of hydrogen, alkyl, alkenyl, alkenyl, alkynyl, alkynyl, alkynyl, alkynyl, (T-butyl) silyl, t-butyldimethylsilyl, t-butyldimethylsilyl, t-butyldimethylsilyl, tributylsilyl, tri Heptyl, bicyclo [2.2.2] octyl, bicyclo [3.2.1] octyl, bicyclo [5.2.0] nonyl, bicyclo [4.2 2] decyl, bicyclo [2.2.2] octyl, 4-pentylbicyclo [2.2.2] octyl, ethenyl, phenylethenyl, ethynyl, phenylethynyl, dimethylamino, diphenylamino, monomethylamino , Monophenylamino, phenyloxy, phenylthio, methoxycarbonyl, ethoxycarbonyl, t-butoxycarbonyl, methylcarbonyl, ethylcarbonyl, benzylcarbonyl or phenyl Carbonyl, and the like. R 1 to R 6 may be the same or different from each other and are independent from each other.

상기 Ar1에 대한 구체적인 예로서는, 치환 또는 비치환된 페닐, 치환 또는 비치환된 나프탈렌, 치환 또는 비치환된 페난트렌, 안트라센, 파이렌, 트리페닐렌, 테트라센, 크리센 등이 있다. 상기 Ar1은 그 임의의 탄소위치 2 이상에서 -(X)n-으로 포함하는 고리의 원소와 결합하여 융합고리를 형성할 수 있다.Specific examples of the Ar 1 include substituted or unsubstituted phenyl, substituted or unsubstituted naphthalene, substituted or unsubstituted phenanthrene, anthracene, pyrene, triphenylene, tetracene, and chrysene. Ar 1 may combine with an element of a ring containing - (X) n - at an arbitrary carbon position 2 or more to form a fused ring.

한편, 치환체 A 는 수소와 할로겐 원자일 수 없다는 점을 제외하고는, R1 와 R6와 동일할 수 있다. 다만, 상기 치환체 A는 추가적으로

Figure 112013070990148-pat00020
형태의 치환체일 수 있다. 이때, Ar3는 치환 또는 비치환된 (C1-C60)알킬렌옥시; 치환 또는 비치환된 (C1-C60)알킬렌티오; 치환 또는 비치환된 (C6-C60)아릴렌옥시; (C6-C60)아릴렌티오; 치환 또는 비치환된 (C6-C60)아릴렌; 또는 (C3-C60)헤테로아릴렌이고, R7은 R1 내지 R6은와 동일하다. On the other hand, substituent A may be the same as R 1 and R 6 , except that it can not be a hydrogen atom or a halogen atom. However, the substituent A is additionally
Figure 112013070990148-pat00020
Lt; / RTI &gt; Wherein Ar 3 is substituted or unsubstituted (C 1 -C 60 ) alkyleneoxy; Substituted or unsubstituted (C 1 -C 60) alkylene-thio; Substituted or unsubstituted (C 6 -C 60 ) aryleneoxy; (C 6 -C 60 ) arylene thio; Substituted or unsubstituted (C 6 -C 60 ) arylene; Or (C 3 -C 60 ) heteroarylene, and R 7 is the same as R 1 to R 6 .

상기 치환체 A의 구체적인 예는 하기와 같을 수 있으나, 이에 한정되는 것은 아니다.Specific examples of the substituent A may be as follows, but are not limited thereto.

Figure 112013070990148-pat00021
Figure 112013070990148-pat00021

Figure 112013070990148-pat00022
Figure 112013070990148-pat00022

한편, 상기 화학식 1로 표시되는 화합물과 관련된 치환기가 치환될 경우, 서로 같거나 다르고, 각각 독립적으로, 할로겐, (C1-C60)알킬, (C6-C60)아릴, (C2-C60)헤테로아릴, N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬, (C3-C60)시클로알킬, 트리(C1-C60)알킬실릴, 디(C1-C60)알킬(C6-C60)아릴실릴, 트리(C6-C60)아릴실릴, 아다만틸, (C7-C60)바이시클로알킬, (C2-C60)알케닐, (C2-C60)알키닐, (C1-C60)알콕시, 시아노, (C1-C60)알킬아미노, (C6-C60)아릴아미노, (C6-C60)아르(C1-C60)알킬, (C6-C60)아릴옥시, (C1-C60)알킬티오, (C6-C60)아릴티오, (C1-C60)알콕시카보닐, (C1-C60)알킬카보닐, (C6-C60)아릴카보닐, 카복실산, 나이트로 또는 하이드록시로 치환될 수 있다. 각각의 치환기는 서로 동일하거나 상이할 수 있다. On the other hand, when the substituents relating to the compound represented by the formula (1) substituted, same or different, each independently, halogen, (C 1 -C 60) alkyl, (C 6 -C 60) aryl, (C 2 - C 60) heteroaryl, N, O, 5-or 6-membered heterocycloalkyl of, containing one or two or more selected from S and Si (C 3 -C 60) cycloalkyl, tri (C 1 -C 60) alkylsilyl, di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl, tri (C 6 -C 60) arylsilyl, adamantyl, (C 7 -C 60) alkyl, bicycloalkyl, (C 2 -C 60) alkenyl, (C 2 -C 60) alkynyl, (C 1 -C 60) alkoxy, cyano, (C 1 -C 60) alkylamino, (C 6 -C 60) aryl amino, (C 6 -C 60) aralkyl (C 1 -C 60) alkyl, (C 6 -C 60) aryloxy, (C 1 -C 60) alkylthio, (C 6 -C 60) arylthio, ( C 1 -C 60) alkoxycarbonyl, (C 1 -C 60) may be substituted with alkylcarbonyl, (C 6 -C 60) arylcarbonyl, carboxylic acid, nitro, or hydroxy. Each substituent may be the same or different from each other.

상기 화학식 1로 표시되는 화합물의 보다 구체적인 예는 하기와 같을 수 있으나, 이에 한정되는 것은 아니다.More specific examples of the compound represented by the formula (1) may be as follows, but are not limited thereto.

Figure 112013070990148-pat00023
Figure 112013070990148-pat00023

Figure 112013070990148-pat00024
Figure 112013070990148-pat00024

Figure 112013070990148-pat00025
Figure 112013070990148-pat00025

Figure 112013070990148-pat00026
Figure 112013070990148-pat00026

Figure 112013070990148-pat00027
Figure 112013070990148-pat00027

Figure 112013070990148-pat00028
Figure 112013070990148-pat00028

Figure 112013070990148-pat00029
Figure 112013070990148-pat00029

Figure 112013070990148-pat00030
Figure 112013070990148-pat00030

Figure 112013070990148-pat00031
Figure 112013070990148-pat00031

Figure 112013070990148-pat00032
Figure 112013070990148-pat00032

Figure 112013070990148-pat00033
Figure 112013070990148-pat00033

Figure 112013070990148-pat00034
Figure 112013070990148-pat00034

Figure 112013070990148-pat00035
Figure 112013070990148-pat00035

Figure 112013070990148-pat00036
Figure 112013070990148-pat00036

Figure 112013070990148-pat00037
Figure 112013070990148-pat00037

Figure 112013070990148-pat00038
Figure 112013070990148-pat00038

Figure 112013070990148-pat00039
Figure 112013070990148-pat00039

Figure 112013070990148-pat00040
Figure 112013070990148-pat00040

Figure 112013070990148-pat00041
Figure 112013070990148-pat00041

한편, 본 발명에 있어서, 알킬, 알콕시 및 그 밖의 알킬관련 치환체는 직쇄 또는 분지쇄 형태를 의미한다.In the present invention, on the other hand, alkyl, alkoxy and other alkyl-related substituents mean straight-chain or branched-chain forms.

본 발명에서, 아릴은 하나의 수소 제거에 의해서 방향족 탄화수소로부터 유도된 유기 라디칼로, 각 고리에 적절하게는 4 내지 7, 바람직하게는 5 또는 6의 고리원자를 포함하는 단일 또는 융합고리계를 포함한다. 구체적인 예로는 페닐, 나프틸, 비페닐, 아트릴, 테트라히드로나프틸, 인다닐(indanyl), 플루오레닐, 페난트릴, 트라이페닐레닐, 피렌일, 페릴렌일, 크라이세닐, 나프타세닐, 플루오란텐일 등을 포함할 수 있다. 하지만, 이에 한정되지는 않는다.In the present invention, aryl is an organic radical derived from aromatic hydrocarbons by removal of one hydrogen, and includes a single or fused ring system, suitably containing from 4 to 7, preferably 5 or 6, ring atoms in each ring do. Specific examples include phenyl, naphthyl, biphenyl, atrile, tetrahydronaphthyl, indanyl, fluorenyl, phenanthryl, triphenylenyl, pyrenyl, perylenyl, And the like. However, the present invention is not limited thereto.

본 발명에서, 헤테로아릴은 방향족 고리 골격 원자로서 N, O, S 및 Si로부터 선택되는 1종 또는 2종 이상의 헤테로원자를 포함하고, 나머지 방향족 고리 골격 원자가 탄소인 아릴그룹을 의미하는 것으로서, 5 또는 6원의 단환 헤테로아릴, 및 하나 이상의 벤젠환과 축합된 다환식 헤테로아릴이며, 부분적으로 포화될 수도 있다. 상기 헤테로아릴기는 고리내 헤테로원자가 산화되거나 사원화되어, 예를 들어 N-옥사이드 또는 4차 염을 형성하는 2가 아릴 그룹을 포함한다. 구체적인 예로 퓨릴, 티오펜일, 피롤릴, 피란일, 이미다졸릴, 피라졸리, 티아졸리, 티아디아졸릴, 이소티아졸릴, 이속사졸릴, 옥사졸릴, 옥사디아졸릴, 트리아진일, 테트라진일, 트리아지일, 테트라진일, 트리아졸릴, 테테르졸릴, 퓨라잔일, 피리딜, 피라진일, 피리미딘일, 피리다진일 등의 단환 헤테로아릴, 벤조퓨란일, 이소벤조퓨란일, 벤조이미다졸릴, 벤조티아졸릴, 벤조이소티아졸릴, 벤조이속사졸릴, 벤조옥사졸릴, 이소인돌릴, 인돌릴, 인다졸릴, 벤조티아디아졸, 퀴놀릴, 이소퀴놀릴, 신놀리닐, 퀴나졸리닐, 퀴놀리진일, 퀴녹살리닐, 카바졸릴, 페난트리딘일, 벤조디옥솔릴 등의 다환식 헤테로아릴 및 이들의 상응하는 N-옥사이드 이들의 4차 염 등을 포함하지만, 이에 한정되지는 않는다.In the present invention, heteroaryl means an aryl group having at least one hetero atom selected from N, O, S and Si as the aromatic ring skeletal atom and the remaining aromatic skeletal atom carbon, 6-membered monocyclic heteroaryl, and condensed polycyclic heteroaryl with one or more benzene rings, and may be partially saturated. The heteroaryl groups include divalent aryl groups in which the heteroatoms in the ring are oxidized or trisubstituted to form, for example, an N-oxide or a quaternary salt. Specific examples include furyl, thiophenyl, pyrrolyl, pyranyl, imidazolyl, pyrazolyl, thiazolyl, thiadiazolyl, isothiazolyl, isoxazolyl, oxazolyl, oxadiazolyl, triazinyl, tetrazinyl, tri Monocyclic heteroaryl such as aziridinyl, tetrazinyl, triazolyl, tetrazolyl, purafanzyl, pyridyl, pyrazinyl, pyrimidinyl and pyridazinyl, benzofuranyl, isobenzofuranyl, benzoimidazolyl, benzo Benzothiadiazolyl, benzoisoxazolyl, benzoxazolyl, isoindolyl, indolyl, indazolyl, benzothiadiazole, quinolyl, isoquinolyl, cinnolinyl, quinazolinyl, quinolizinyl, But are not limited to, polycyclic heteroaryls such as quinoxalinyl, carbazolyl, phenanthridinyl, benzodioxolyl and the like and their corresponding N-oxides quaternary salts thereof.

상기 기술된 본 발명의 화합물은 열안정성이 뛰어나므로 수명이 길고, 발광효율 및 색좌표가 우수하다는 특성을 갖는다. 특히, 본 발명의 화합물은 청색, 녹색 형광용 재료로 적합하다.
The compound of the present invention described above is excellent in thermal stability, has a long lifetime, and is excellent in luminous efficiency and color coordinates. Particularly, the compound of the present invention is suitable as a material for blue and green fluorescence.

Ⅱ. Ⅱ. 유기전계발광소자Organic electroluminescent device

본 발명은 또한 제 1 전극; 제 2 전극; 및 상기 제 1 전극과 제 2 전극 사이에 위치하고 상기 화학식 1로 표시되는 화합물을 포함하는 유기막을 포함하는 유기전계발광소자를 제공한다.The present invention also relates to a liquid crystal display comprising a first electrode; A second electrode; And an organic layer disposed between the first electrode and the second electrode and including a compound represented by the formula (1).

상기 유기막은 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층으로 이루어진 군에서 선택되는 1종 또는 2종 이상이고, 정공주입층, 정공수송층 및 발광층으로 이루어진 군에서 선택되는 1종 또는 2종 이상인 것이 바람직하다. 왜냐하면, 상기 화학식 1의 화합물이 정공주입 및 정공전달 특성이 우수하여 정공주입층 또는 정공수송층 재료로 유용하기 때문이다. 그중에서도 정공전달 특성이 우수하여, 정공수송층 재료로 보다 유용하다. 또한, 상기 화학식 1의 화합물은 발광층에서 도펀트로 에너지를 전달하는 특성이 우수하여 청색, 녹색, 적색 형광 및 인광 소자의 호스트 재료로 유용하다. 상기 화학식 1의 화합물은 인광 소자 보다는 형광 소자의 호스트 재료로 보다 유용하다.The organic layer may be one or more selected from the group consisting of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer, and may be one or two selected from the group consisting of a hole injection layer, Or more. This is because the compound of Formula 1 is excellent in hole injecting and hole transporting properties and is useful as a hole injecting layer or a hole transporting layer material. Among them, the hole transporting property is excellent, and it is more useful as the hole transporting layer material. The compound of formula (1) is excellent in the property of transferring energy from the light emitting layer to the dopant and is useful as a host material for blue, green, red fluorescence and phosphorescent devices. The compound of Formula 1 is more useful as a host material of a fluorescent device than a phosphorescent device.

한편, 상기 유기막은 화학식 1의 화합물 이외에, 하기 화학식 14로 표시되는 화합물, 하기 화학식 15로 표시되는 화합물 및 이들의 혼합물로 이루어진 군에서 선택되는 1종을 추가로 포함할 수 있다.The organic layer may further include a compound selected from the group consisting of a compound represented by the following formula (14), a compound represented by the following formula (15), and a mixture thereof in addition to the compound represented by the formula (1).

<화학식 14> <화학식 15>&Lt; Formula 14 > < EMI ID =

Figure 112013070990148-pat00042
Figure 112013070990148-pat00043
Figure 112013070990148-pat00042
Figure 112013070990148-pat00043

상기 화학식 14 및 화학식 15에서, In the above Formulas 14 and 15,

Ar5는 (C6-C60)아릴 또는 (C4-C60)헤테로아릴이며,Ar 5 is (C 6 -C 60 ) aryl or (C 4 -C 60 ) heteroaryl,

Ar6 및 Ar7는 서로 같거나 다를 수 있고, 각각 독립적으로, 치환 또는 비치환된 (C6-C60)아릴, 치환 또는 비치환된 (C4-C60)헤테로아릴, (C6-C60)아릴아미노, N, O 및 S로부터 선택된 하나 이상을 포함하는 5원 내지 6원의 헤테로시클로알킬 또는 치환 또는 비치환된 (C3-C60)시클로알킬이며, 상기 Ar6 및 Ar7는 융합고리를 포함하거나 포함하지 않는 지환족 고리, 단일환 또는 다환의 방향족 고리를 형성할 수 있으며, Ar 6 and Ar 7, which may be the same or different, each independently represent a substituted or unsubstituted (C 6 -C 60 ) aryl, substituted or unsubstituted (C 4 -C 60 ) heteroaryl, (C 6 - C 60) arylamino, N, O and (C 3 -C 60 unsubstituted 5-6 membered heterocycloalkyl or a substituted or unsubstituted, including at least one selected from the S), and cycloalkyl, wherein Ar 6 and Ar 7 May form an alicyclic ring, a monocyclic or polycyclic aromatic ring with or without a fused ring,

Ar8는 서로 독립적으로, (C6-C60)아릴렌 또는 (C4-C60)헤테로아릴렌이고, 상기 Ar8은 융합고리를 포함하거나 포함하지 않는 지환족 고리, 단일환 또는 다환의 방향족 고리를 형성할 수 있으며,Ar 8 is, independently of each other, (C 6 -C 60 ) arylene or (C 4 -C 60 ) heteroarylene, wherein Ar 8 is an alicyclic ring with or without a fused ring, a monocyclic or polycyclic An aromatic ring may be formed,

a는 1 내지 4이고, b는 1 내지 4이고, c는 0 내지 1이다.
a is from 1 to 4, b is from 1 to 4, and c is from 0 to 1.

상기 화학식 14 및 15의 예로는 하기와 같은 화합물을 들 수 있으나, 이에 한정되는 것은 아니다.Examples of the above-mentioned formulas (14) and (15) include, but are not limited to, the following compounds.

Figure 112013070990148-pat00044
Figure 112013070990148-pat00044

상기 유기막은 또한 상기 화합물 이외에 아릴아민 화합물, 스티릴아릴아민 화합물 및 이들의 혼합물로 이루어진 군에서 선택되는 1종을 추가로 포함할 수 있다.The organic film may further include one species selected from the group consisting of an arylamine compound, a styrylarylamine compound, and a mixture thereof in addition to the above compound.

또한 상기 유기막은 상기 화합물들 이외에 1족, 2족, 4주기, 5주기 전이금속, 란탄계열금속 및 d-전이원소의 유기금속으로 이루어진 군으로부터 선택되는 1종 또는 2종 이상을 추가로 포함할 수 있다.
In addition, the organic film may further include one or more species selected from the group consisting of Group 1, Group 2, Group 4, Periodic transition metal, Lanthanide series metal and d- .

본 발명의 유기전계발광소자를 보다 상세하게 살펴보면, 상기 화학식 1의 화합물을 함유하는 유기막은 정공주입층, 정공수송층 또는 발광층일 수 있고, 정공주입 및 정공수송 기능을 동시에 갖는 단일막일 수 있다. 또는 상기 화학식 1로 표시되는 헤테로고리 화합물을 포함한 유기막은 발광층일 수도 있다. 이때, 상기 화학식 1로 표시되는 화합물은 청색, 녹색 또는 적색의 형광 또는 인광 재료의 호스트 재료로서 사용될 수 있다. 더욱 바람직하게는, 청색의 형광 호스트 재료로 사용되는 것이다.The organic layer containing the compound of Formula 1 may be a hole injection layer, a hole transport layer, or a light emitting layer, and may be a single layer having both a hole injection function and a hole transport function at the same time. Or an organic layer containing a heterocyclic compound represented by the general formula (1) may be a light emitting layer. At this time, the compound represented by the formula (1) can be used as a blue, green or red fluorescent or phosphorescent host material. More preferably, it is used as a blue fluorescent host material.

바람직하게는 상기 화학식 1로 표시되는 화합물을 포함한 유기막은 정공주입층 또는 정공수송층이다. 전술한 바와 같은 유기전계발광소자는 필요에 따라, 정공주입층, 정공수송층, 전자저지층, 발광층, 정공저지층, 전자수송층 및 전자주입층 중 하나 이상의 층을 더 구비할 수 있고, 필요에 따라 상기 유기층들을 2층의 유기층으로 형성하는 것도 가능하다.Preferably, the organic layer containing the compound of Formula 1 is a hole injection layer or a hole transport layer. The organic electroluminescent device may further include at least one of a hole injecting layer, a hole transporting layer, an electron blocking layer, a light emitting layer, a hole blocking layer, an electron transporting layer and an electron injecting layer, The organic layers may be formed of two organic layers.

예를 들어, 본 발명을 따르는 유기전계발광소자는 제 1 전극/정공주입층/발광층/제 2 전극, 제 1 전극/정공주입층/정공수송층/발광층/전자수송층/제 2 전극 또는 제 1 전극/정공주입층/정공수송층/발광층/전자수송층/전자주입층/제 2 전극 구조를 가질 수 있다. 또는 상기 유기전계발광소자는 제 1 전극/정공주입 기능 및 정공수송 기능을 동시에 갖는 단일막/발광층/전자수송층/제 2 전극 또는 제 1 전극/정공주입 기능 및 정공 수송 기능을 동시에 갖는 단일막/발광층/전자수송층/전자주입층/제 2 전극 구조를 가질 수 있다.For example, the organic electroluminescent device according to the present invention includes a first electrode / a hole injection layer / a light emitting layer / a second electrode, a first electrode / a hole injection layer / a hole transport layer / a light emitting layer / an electron transport layer / / Hole injection layer / hole transporting layer / light emitting layer / electron transporting layer / electron injecting layer / second electrode structure. Alternatively, the organic electroluminescent device may include a single film / light emitting layer / electron transporting layer / second electrode having a first electrode / hole injecting function and a hole transporting function, or a single electrode / hole transporting layer having a first electrode / hole injecting function and a hole transporting function, Emitting layer / electron transporting layer / electron injecting layer / second electrode structure.

본 발명에 따르는 유기전계발광소자는 전면 발광형, 배면 발광형 등 다양한 구조로 적용 가능하다.The organic electroluminescent device according to the present invention can be applied to various structures such as a top emission type and a bottom emission type.

본 발명에 따르는 유기전계발광소자의 제조방법은 하기와 같다.A method of manufacturing an organic electroluminescent device according to the present invention is as follows.

먼저 기판 상부에 높은 일함수를 갖는 제 1 전극용 물질을 증착법 또는 스퍼터링법 등에 의해 형성하여 제 1 전극을 형성한다. 상기 제 1 전극은 애노드(Anode) 또는 캐소드(cathode)일 수 있다. 여기에서 기판으로는 통상적인 유기전계발광소자에서 사용되는 기판을 사용하는데 기계적 강도, 열적 안정성, 투명성, 표면 평활성, 취급용이성 및 방수성이 우수한 유리 기판 또는 투명 플라스틱 기판이 바람직하다. 제 1 전극용 물질로는 전도성이 우수한 산화인듐주석(ITO), 산화인듐아연(IZO), 산화주석(SnO2), 산화아연(ZnO), Al, Ag, Mg 등을 이용할 수 있으며, 투명 전극 또는 반사 전극으로 형성될 수 있다.First, a first electrode material having a high work function is formed on a substrate by a vapor deposition method, a sputtering method, or the like to form a first electrode. The first electrode may be an anode or a cathode. Here, the substrate used in a typical organic electroluminescent device is preferably a glass substrate or a transparent plastic substrate having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and waterproofness. As the first electrode material, indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO 2 ), zinc oxide (ZnO), Al, Ag, Mg, Or a reflective electrode.

다음으로, 상기 제 1 전극 상부에 진공증착법, 스핀코팅법, 캐스트법, LB법 등과 같은 다양한 방법을 이용하여 정공주입층(HIL)을 형성할 수 있다.Next, a hole injection layer (HIL) may be formed on the first electrode by various methods such as a vacuum deposition method, a spin coating method, a casting method, and an LB method.

진공증착법에 의하여 정공주입층을 형성하는 경우, 그 증착 조건은 정공주입층의 재료로서 사용하는 화합물, 목적으로 하는 정공주입층의 구조 및 열적 특성 등에 따라 다르지만, 일반적으로 증착온도 100 내지 500℃, 진공도 10-8 내지 10-3torr, 증착속도 0.01 내지 100Å/sec, 막 두께는 통상 10Å 내지 5㎛ 범위에서 적절히 선택하는 것이 바람직하다.When the hole injection layer is formed by the vacuum deposition method, the deposition conditions vary depending on the compound used as the material of the hole injection layer, the structure and the thermal characteristics of the desired hole injection layer, and the like. In general, A degree of vacuum of 10 &lt; -8 &gt; to 10 &lt; -3 &gt; torr, a deposition rate of 0.01 to 100 ANGSTROM / sec and a film thickness of 10 ANGSTROM to 5 mu m.

스핀코팅법에 의하여 정공주입층을 형성하는 경우, 그 코팅 조건은 정공주입층의 재료로서 사용하는 화합물, 목적하는 하는 정공주입층의 구조 및 열적 특성에 따라 상이하지만, 약 2000rpm 내지 5000rpm의 코팅 속도, 코팅 후 용매 제거를 위한 열처리 온도는 약 80℃ 내지 200℃의 온도 범위에서 적절히 선택하는 것이 바람직하다.When the hole injection layer is formed by the spin coating method, the coating conditions vary depending on the compound used as the material of the hole injection layer, the structure and the thermal properties of the desired hole injection layer, but the coating speed is preferably from about 2000 rpm to 5000 rpm , And the heat treatment temperature for removing the solvent after coating is suitably selected within a temperature range of about 80 캜 to 200 캜.

상기 정공주입층 물질로는 전술한 바와 같은 화학식 1로 표시되는 화합물을 이용하거나, 공지된 정공주입층 물질을 사용할 수도 있는데, 예를 들면, 미국특허 제4,356,429호에 개시된 구리프탈로시아닌 등의 프탈로시아닌 화합물 또는 Advanced Material, 6, p.677(1994)에 기재되어 있는 스타버스트형 아민 유도체류인 TCTA, m-MTDATA, m-MTDAPB, 용해성이 있는 전도성 고분자인 Pani/DBSA (Polyaniline/Dodecylbenzenesulfonic acid: 폴리아닐린/도데실벤젠술폰산) 또는 PEDOT/PSS (Poly(3,4-ethylenedioxythiophene)/Poly(4-styrenesulfonate):폴리(3,4-에틸렌디옥시티오펜)/폴리(4-스티렌술포네이트)), Pani/CSA (Polyaniline/Camphor sulfonic acid:폴리아닐린/캠퍼술폰산) 또는 PANI/PSS (Polyaniline)/Poly (4-styrene-sulfonate):폴리아닐린)/폴리(4-스티렌술포네이트)) 등을 사용할 수 있다.As the hole injection layer material, a compound represented by Formula 1 as described above may be used, or a known hole injection layer material may be used. For example, a phthalocyanine compound such as copper phthalocyanine disclosed in U.S. Patent No. 4,356,429 TCAD, m-MTDATA, m-MTDAPB, starburst amine derivatives as described in Advanced Material, 6, p. 677 (1994), and polyaniline / dodecylbenzenesulfonic acid / dodecylbenzene sulfonate (DBI), a soluble conductive polymer Poly (3,4-ethylenedioxythiophene) / poly (4-styrenesulfonate) / poly (4-styrenesulfonate)), Pani / CSA (Polyaniline / camphor sulfonic acid: polyaniline / camphorsulfonic acid) or PANI / PSS (polyaniline) / poly (4-styrene-sulfonate): polyaniline) / poly (4-styrenesulfonate).

상기 정공주입층의 두께는 약 100Å 내지 10000Å 바람직하게는 100Å 내지 1000Å일 수 있다. 상기 정공주입층의 두께가 100Å 미만인 경우, 정공주입 특성이 저하될 수 있으며, 상기 정공주입층의 두께가 10000Å를 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.The thickness of the hole injection layer may be about 100 Å to 10000 Å, preferably 100 Å to 1000 Å. If the thickness of the hole injection layer is less than 100 angstroms, the hole injection characteristics may be degraded. If the thickness of the hole injection layer exceeds 10000 angstroms, the driving voltage may increase.

다음으로 상기 정공주입층 상부에 진공증착법, 스핀코팅법, 캐스트법, LB법 등과 같은 다양한 방법을 이용하여 정공수송층(HTL)을 형성할 수 있다. 진공증착법 및 스핀팅법에 의하여 정공수송층을 형성하는 경우, 그 증착조건 및 코팅조건은 사용하는 화합물에 따라 다르지만, 일반적으로 정공주입층의 형성과 거의 동일한 조건범위 중에서 선택된다.Next, a hole transport layer (HTL) may be formed on the hole injection layer by various methods such as a vacuum deposition method, a spin coating method, a casting method, and an LB method. In the case of forming the hole transporting layer by the vacuum deposition method and the sputtering method, the deposition conditions and the coating conditions vary depending on the compound used, but are generally selected from substantially the same range of conditions as the formation of the hole injection layer.

상기 정공수송층 물질은 전술한 바와 같은 화학식 1로 표시되는 화합물이거나 공지된 정공수송층 물질을 이용할 수도 있는데, 예를 들면, N-페닐카바졸, 폴리비닐카바졸 등의 카바졸 유도체, 4,4'-비스[N-(1-나프틸)-N-페닐아미노]비페닐(NPB), N,N'-비스(3-메틸페닐)-N,N'-디페닐-[1,1-비페닐]-4,4'-디아민(TPD), N,N'-디(나프탈렌-1-일)-N,N'-디페닐 벤지딘(α-NPD) 등의 방향족 축합환을 가지는 통상적인 아민 유도체 등이 사용된 주입층의 형성과 거의 동일한 조건범위 중에서 선택된다.The hole transport layer material may be a compound represented by the general formula (1) or a known hole transport layer material may be used. For example, carbazole derivatives such as N-phenylcarbazole and polyvinylcarbazole, (NPB), N, N'-bis (3-methylphenyl) -N, N'-diphenyl- [1,1-biphenyl ] -4,4'-diamine (TPD), and N, N'-di (naphthalen-1-yl) -N, N'-diphenylbenzidine Is selected from the same range of conditions as the formation of the injection layer used.

상기 전자주입층의 두께는 약 1Å 내지 100Å 바람직하게는 5Å 내지 90Å일 수 있다. 상기 전자주입층의 두께가 1Å 미만인 경우, 전자주입 특성이 저하될 수 있으며, 상기 전자주입층의 두께가 100Å 초과하는 경우, 구동전압이 상승할 수 있기 때문이다.The thickness of the electron injection layer may be about 1 to about 100, preferably about 5 to about 90. If the thickness of the electron injection layer is less than 1 angstrom, the electron injection characteristics may be degraded. If the thickness of the electron injection layer exceeds 100 angstroms, the driving voltage may increase.

마지막으로 전자주입층 상부에 진공증착법이나 스퍼터링법 등의 방법을 이용하여 제 2 전극을 형성할 수 있다. 상기 제 2 전극은 캐소드 또는 애노드로 사용될 수 있다. 상기 제 2 전극 형성용 물질로는 낮은 일함수를 가지는 금속, 합금, 전기전도성 화합물 및 이들의 혼합물을 사용할 수 있다. 구체적인 예로서는 리튬(Li), 마그네슘(Mg), 알루미늄(Al), 알루미늄-리튬(Al-Li), 칼슘(Ca), 마그네슘-인듐(Mg-In), 마그네슘-은(Mg-Ag)등을 들 수 있다. 또한, 전면 발광 장치를 얻기 위하여 ITO, IZO를 사용한 투명 캐소드를 사용할 수도 있다.Finally, the second electrode can be formed on the electron injection layer by a vacuum evaporation method, a sputtering method, or the like. The second electrode may be used as a cathode or an anode. As the material for forming the second electrode, a metal, an alloy, an electrically conductive compound having a low work function, or a mixture thereof may be used. Specific examples thereof include lithium (Li), magnesium (Mg), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), magnesium- . A transparent cathode using ITO or IZO may also be used to obtain a front light emitting device.

본 발명을 따르는 유기전계발광소자는 다양한 형태의 평판 표시 장치, 예를 들면 수동 매트릭스 유기 발광 표시 장치 및 능동 매트릭스 유기 발광 표시 장치에 구비될 수 있다. 특히, 능동 매트릭스 유기 발광 표시 장치에 구비되는 경우, 기판 측에 구비된 제 1 전극은 화소 전극으로서 박막 트랜지스터의 소스 전극 또는 드레인 전극과 전기적으로 연결될 수 있다. 또한, 상기 유기전계발광소자는 양면으로 화면을 표시할 수 있는 평판 표시 장치에 구비될 수 있다.The organic electroluminescent device according to the present invention may be provided in various types of flat panel display devices, for example, a passive matrix organic light emitting display device and an active matrix organic light emitting display device. In particular, when the active matrix organic light emitting display device is provided, the first electrode provided on the substrate side may be electrically connected to the source electrode or the drain electrode of the thin film transistor as the pixel electrode. In addition, the organic electroluminescent device may be provided in a flat panel display device capable of displaying a screen on both sides.

본 발명의 유기전계발광소자는 수명이 길고 발광효율이 우수하고, 색순도가 높다.The organic electroluminescent device of the present invention has a long lifetime, excellent luminous efficiency, and high color purity.

Ⅲ. 태양전지Ⅲ. Solar cell

본 발명은 제 1 전극; 제 2 전극; 및 상기 제 1 전극과 제 2 전극 사이에 위치하고 상기 화학식 1로 표시되는 화합물을 포함하는 유기막을 포함하는 태양전지를 제공한다.The present invention relates to a plasma display panel comprising a first electrode; A second electrode; And an organic layer disposed between the first electrode and the second electrode and including a compound represented by the general formula (1).

상기 화학식 1의 화합물은 정공주입 특성 및 정공전달 특성이 우수한 정공수송층 재료로서 유용하다. 화학식 1의 화합물을 함유하는 유기막은 본 발명의 태양전지에서 정공주입층, 정공수송층일 수 있고, 정공주입 및 정공수송 기능을 동시에 갖는 단일막일 수 있다. 바람직하게는 상기 화학식 1로 표시되는 화합물을 포함한 유기막은 정공주입층 또는 정공수송층이다.The compound of Formula 1 is useful as a hole transport layer material having excellent hole injection properties and hole transport properties. The organic film containing the compound of formula (1) may be a hole injection layer, a hole transporting layer, or a single film having both a hole injection function and a hole transport function simultaneously in the solar cell of the present invention. Preferably, the organic layer containing the compound of Formula 1 is a hole injection layer or a hole transport layer.

본 발명의 태양전지는 필요에 따라, 정공주입층, 정공수송층, 전자저지층, 버퍼층, 정공저지층, 전자수송층 및 전자주입층 중 하나 이상의 층을 더 구비할 수 있고, 필요에 따라 상기 유기층들을 2층의 유기층으로 형성하는 것도 가능하다.
The solar cell of the present invention may further include at least one layer of a hole injecting layer, a hole transporting layer, an electron blocking layer, a buffer layer, a hole blocking layer, an electron transporting layer and an electron injecting layer, It is also possible to form the organic layer as two layers.

이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. Hereinafter, the present invention will be described in more detail with reference to Examples.

본 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것이며, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다. The present invention is intended to more specifically illustrate the present invention, and the scope of the present invention is not limited to these embodiments.

<실시예><Examples>

합성예Synthetic example 1: 화합물 1의 제조 1: Preparation of compound 1

하기 반응식 1의 반응 경로를 거쳐 화합물 1을 합성하였다.Compound 1 was synthesized via the reaction path of Scheme 1 below.

<반응식 1><Reaction Scheme 1>

Figure 112013070990148-pat00045
Figure 112013070990148-pat00045

(1) 화합물 1-1의 제조 (1) Production of Compound 1-1

9-브로모안트라센 10g(39㏖), 2-포밀페닐보론산 7g(47m㏖), Pd(PPh3)4 4.5g(3.9m㏖) 및 K2CO3 10.5g(76m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 목적 화합물 1-1 8g(73%)을 수득하였다.9-bromo-anthracene 10g (39㏖), 2- formyl-phenylboronic acid 7g (47m㏖), Pd (PPh 3) 4 4.5g (3.9m㏖) and K 2 CO 3 10.5 g (76 mmol) of the compound was dissolved in toluene / ethanol / distilled water (200 ml / 50 ml / 40 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 8 g (73%) of the desired compound 1-1.

(2) 화합물 1-2의 제조(2) Preparation of Compound 1-2

IPy2BF4 21g(56m㏖)을 디클로로메탄에 녹인 후 -78℃로 냉각하였다. HBF4 18.2g(112m㏖)을 가한 뒤 10분 동안 -78℃에서 교반하였다. 고체를 여과 후 여액을 -60?로 냉각한 뒤, 화합물 1-1 8g(28m㏖)을 천천히 첨가하였다. 반응이 완결되면 얼음물로 반응종결 후 유기물을 추출하였다. 유기물을 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 목적 화합물 1-2 4.7g(60%)을 수득하였다.IPy2BF4 21g (56mmol) was dissolved in dichloromethane and then cooled to -78 ° C. HBF4 18.2 g (112 mmol) of the mixture was added, and the mixture was stirred at -78 캜 for 10 minutes. The solid was filtered, and the filtrate was cooled to -60 DEG C, followed by slowly adding 8 g (28 mmol) of Compound 1-1. When the reaction was completed, the organic material was extracted with ice water after completion of the reaction. The organics were dissolved in MgSO44, The solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as developing solvents to obtain 4.7 g (60%) of the desired compound 1-2.

(3) 화합물 1-3의 제조(3) Preparation of Compound 1-3

화합물 1-2 4.7g(17m㏖)을 다이에틸에테르 100㎖에 녹이고, AlCl3 2.7g(20.4m㏖)을 천천히 첨가하였다. 이를 15분 동안 교반한 후, 0℃로 냉각하고 리튬알루미늄하이드라이드(LAH) 1g(26m㏖)를 천천히 첨가하였다. 이를 1시간 동안 환류 교반한 후 반응이 완결되면 상온으로 천천히 냉각하고, 여기에 EA를 거품이 일어나지 않을 때까지 천천히 넣어주었다. 그 후, 6N HCl 20㎖을 넣어주고, 증류수와 에틸아세테이트로 추출하였다. 유기물을 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디틀로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 화합물 1-3.4g(90%)을 수득하였다.4.7 g (17 mmol) of Compound 1-2 was dissolved in 100 ml of diethyl ether, and 2.7 g (20.4 mmol) of AlCl 3 was added slowly. It was stirred for 15 minutes, then cooled to 0 ° C and 1 g (26 mmol) of lithium aluminum hydride (LAH) was slowly added. This was refluxed for 1 hour. After the reaction was completed, the reaction mixture was slowly cooled to room temperature, and EA was slowly added thereto until no bubbles were formed. Then, 20 ml of 6N HCl was added thereto, and the mixture was extracted with distilled water and ethyl acetate. The organic layer was dried over MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography to give 1-3.4 g (90%) of the compound.

(4) 화합물 1-4의 제조(4) Preparation of compounds 1-4

화합물 1-3 4g(15m㏖)을 DMSO 40㎖에 녹인 다음, 상온에서 소듐 tert-부톡사이드 10.7g(112m㏖)를 넣어주고 70℃에서 15분 동안 교반하였다. 이에 요오드화 메틸 19g(132m㏖)을 천천히 첨가하고 1시간 동안 더 교반하였다. 반응이 완결되면 상온에서 냉각하고 증류수를 넣어 20분간 교반하였다. 이때 고체가 생성되는데 이를 여과하고, 얻어진 고체를 에탄올과 아세톤으로 재결정하여 목적 화합물 1-4 2.6g(60%)을 수득하였다.4 g (15 mmol) of Compound 1-3 was dissolved in 40 ml of DMSO, 10.7 g (112 mmol) of sodium tert-butoxide was added at room temperature, and the mixture was stirred at 70 ° C for 15 minutes. 19 g (132 mmol) of methyl iodide was slowly added thereto and further stirred for 1 hour. When the reaction was completed, the reaction mixture was cooled at room temperature, and distilled water was added thereto, followed by stirring for 20 minutes. At this time, a solid was formed. The solid was filtered and the resulting solid was recrystallized from ethanol and acetone to obtain 2.6 g (60%) of the desired compound 1-4.

(5) 화합물 1-5의 제조(5) Preparation of compounds 1-5

화합물 1-4 2.6g(8.8m㏖)을 DMF 30㎖에 녹이고, N-브로모숙신이미드 1.6g(8.8m㏖)을 천천히 첨가하였다. 이를 상온에서 하루 동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기물을 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼 크로마토그래피로 정제하여 목적 화합물 1-5 2.6g(80%)을 수득하였다.2.6 g (8.8 mmol) of Compound 1-4 was dissolved in 30 ml of DMF, and 1.6 g (8.8 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic material was dried over MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 2.6 g (80%) of the desired compound 1-5.

(6) 화합물 1의 제조(6) Production of Compound 1

화합물 1-5 10g(26.8m㏖), 페닐보론산 3.9g(32m㏖), Pd(PPh3)4 4.5g(3.1m㏖) 및 K2CO3 7.4g(53.6m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 최종 화합물인 화합물 1, 8.4g(85%)을 수득하였다.Compound 1-5 10g (26.8m㏖), phenylboronic acid 3.9g (32m㏖), Pd (PPh 3) 4 4.5g (3.1m㏖) and K 2 CO 3 7.4g (53.6m㏖) toluene / ethanol / Distilled water (200 ml / 50 ml / 40 ml), followed by stirring at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic material was dried over MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was purified by column chromatography using dichloromethane and hexane as eluent to obtain 8.4 g (85%) of the final compound, Compound 1.

합성예Synthetic example 2: 화합물 42의 제조 2: Preparation of compound 42

하기 반응식 2의 반응 경로를 거쳐 화합물 42를 합성하였다.Compound 42 was synthesized via the reaction path of Reaction Scheme 2 below.

<반응식 2><Reaction Scheme 2>

Figure 112013070990148-pat00046
Figure 112013070990148-pat00046

(1) 화합물 2-1의 제조(1) Production of Compound 2-1

화합물 1-5 10g(26.8m㏖), 4-브로모페닐보론산 6.4g(32m㏖), Pd(PPh3)4 4.5g(2.7m㏖) 및 K2CO3 7.4g(53.6m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 목적 화합물 2-1 10.7g(80%)을 수득하였다.Compound 1-5 10g (26.8m㏖), 4- bromo-phenyl boronic acid 6.4g (32m㏖), Pd (PPh 3) 4 4.5g (2.7m㏖) and K 2 CO 3 7.4g (53.6m㏖) Was dissolved in toluene / ethanol / distilled water (200 ml / 50 ml / 40 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was removed by column chromatography using dichloromethane and hexane as eluent to obtain 10.7 g (80%) of the target compound 2-1.

(2) 화합물 42의 제조(2) Preparation of Compound 42

화합물 2-1 5g(11.1m㏖), 9,9-디메틸플루오렌-2-보론산보론산 3.2g (13.3m㏖), Pd(PPh3)4 1.3g(1.1m㏖) 및 K2CO3 3.1g(22.2m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 최종 화합물인 화합물 42, 5g(80%)을 수득하였다.Compound 2-1 5g (11.1m㏖), 9,9- dimethyl-fluorene-2-boronic acid walk 3.2g (13.3m㏖), Pd (PPh3 ) 4 1.3g (1.1m㏖) and K 2 CO 3 3.1 g (22.2 mmol) was dissolved in toluene / ethanol / distilled water (100 ml / 25 ml / 20 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off using dichloromethane and hexane as eluent to give 42 g of the final compound (80%).

합성예Synthetic example 3: 화합물 77의 제조 3: Preparation of compound 77

하기 반응식 3의 반응 경로를 거쳐 화합물 77를 합성하였다.Compound 77 was synthesized via the reaction path of Reaction Scheme 3 below.

<반응식 3><Reaction Scheme 3>

Figure 112013070990148-pat00047
Figure 112013070990148-pat00047

(1) 화합물 3-1의 제조(1) Preparation of Compound 3-1

9-브로모안트라센 20g(78m㏖), 2-메톡시페닐보론산 14.2g(93m㏖), Pd(PPh3)4 7.8g(7.8m㏖) 및 K2CO3 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 목적 화합물 3-1 20g(90%)을 수득하였다.9-bromo-anthracene 20g (78m㏖), 2- methoxyphenyl boronic acid 14.2g (93m㏖), Pd (PPh3 ) 4 7.8g (7.8m㏖) and K 2 CO 3 21.5g (156m㏖) toluene / Ethanol / distilled water (390 ml / 97 ml / 78 ml), followed by stirring at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as developing solvents to obtain 20 g (90%) of the target compound 3-1.

(2) 화합물 3-2의 제조(2) Preparation of compound 3-2

화합물 3-1 13g(45.7m㏖)을 디클로로메탄 130㎖에 녹인 후 0℃로 냉각하였다. 여기에 보론트리브로마이드 92㎖(92m㏖)를 천천히 첨가하였다. 온도를 상온으로 가온한 뒤 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 톨루엔 용매 하에서 교반한 뒤 여과하여 목적 화합물 3-2 11g(89%)을 수득하였다.13 g (45.7 mmol) of the compound 3-1 was dissolved in 130 ml of dichloromethane and then cooled to 0 占 폚. 92 ml (92 mmol) of boron tribromide was slowly added thereto. The temperature was warmed to room temperature and then stirred. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4, and the solvent was removed using a rotary evaporator. The mixture was stirred in a toluene solvent and filtered to obtain 11 g (89%) of the target compound 3-2.

(3) 화합물 3-3의 제조(3) Preparation of compound 3-3

화합물 3-2 11g(40m㏖)을 디클로로메탄에 녹인 후 2,6-루티딘(2,6-lutidine) 7.1㎖(61m㏖)을 넣고 온도를 -30℃로 냉각한 뒤 교반하였다. 여기에 트리플루오로메탄설포닉 언하이드라이드 8.2㎖(49m㏖)을 천천히 첨가하였다. 온도를 0?로 가온한 뒤 1시간 동안 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 목적 화합물 3-3 15g(93%)을 수득하였다.11 g (40 mmol) of the compound 3-2 was dissolved in dichloromethane, 7.1 ml (61 mmol) of 2,6-lutidine was added, and the mixture was cooled to -30 ° C and stirred. To this was added slowly 8.2 ml (49 mmol) of trifluoromethanesulfonic anhydride. The temperature was raised to 0 ° C and stirred for 1 hour. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 15 g (93%) of the target compound 3-3.

(4) 화합물 3-4의 제조(4) Preparation of compound 3-4

화합물 3-3 15g(37.3m㏖), Pd(PPh3)2Cl2 2.6g(3.7m㏖), 리튬클로라이드 4.7g(112m㏖) 및 DBU 6.7㎖(44.7m㏖)을 디메틸포름이미드 190㎖에 녹인 후 140℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 목적 화합물 3-4 7.5g(80%)을 수득하였다.Compound 3-3 15g (37.3m㏖), Pd ( PPh 3) 2 Cl 2 2.6g (3.7m㏖), lithium chloride 4.7g (112m㏖) and DBU 6.7㎖ the mid-dimethylformamide to 190 (44.7m㏖) Ml, followed by stirring at 140 占 폚. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 7.5 g (80%) of the target compound 3-4.

(5) 화합물 3-5의 제조(5) Preparation of compound 3-5

화합물 3-4 7.5g(30m㏖)을 DMF 100㎖에 녹이고, N-브로모숙신이미드 5.5g(30m㏖)을 천천히 첨가하였다. 이를 상온에서 하루 동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼 크로마토그래피로 정제하여 목적 화합물 3-5 7.4g(75%)을 수득하였다.7.5 g (30 mmol) of the compound 3-4 was dissolved in 100 ml of DMF, and 5.5 g (30 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4, and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 7.4 g (75%) of the target compound 3-5.

(6) 화합물 77의 제조(6) Preparation of Compound 77

화합물 3-5 5g(15m㏖), 디베조티오펜-2-닐 보론산 4.1g(18m㏖), Pd(PPh3)4 1.7g(1.5m㏖) 및 K2CO3 4.1g(30m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100?에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거 한 후 디클로로메탄과 헥산을 전개용매로 하여 컬럼크로마토그래피로 정제하여 최종 화합물인 화합물 77, 5.5g(85%)을 수득하였다.Compound 3-5 5g (15m㏖), dibe joti carbonyl-2-boronic acid 4.1g (18m㏖), Pd (PPh 3) 4 1.7g (1.5m㏖) and K 2 CO 3 4.1g (30m㏖) Was dissolved in toluene / ethanol / distilled water (100 ml / 25 ml / 20 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure using dichloromethane and hexane as eluent to give 77 g (85%) of the final compound 77.

합성예Synthetic example 4: 화합물 169의 제조 4: Preparation of compound 169

하기 화학 반응식 4의 반응 경로를 거쳐 화합물 169를 합성하였다.Compound 169 was synthesized via the reaction path of Reaction Scheme 4 below.

<반응식 4><Reaction Scheme 4>

Figure 112013070990148-pat00048
Figure 112013070990148-pat00048

(1) 화합물 4-1의 제조(1) Preparation of compound 4-1

9-브로모안트라센 20g(78m㏖), 2-니트로페닐보론산 15.5g(93m㏖), Pd(PPh3)4 9g(7.8m㏖) 및 K2CO3 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100?에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 4-1 20g(85%)을 수득하였다.9-bromo-anthracene 20g (78m㏖), 2- nitro-phenyl boronic acid 15.5g (93m㏖), Pd (PPh 3) 4 9g (7.8m㏖) and K 2 CO 3 21.5g (156m㏖) toluene / Dissolved in ethanol / distilled water (390 ml / 97 ml / 78 ml) and stirred at 100 ?. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 20 g (85%) of the target compound 4-1.

(2) 화합물 4-2의 제조(2) Preparation of compound 4-2

화합물 4-1 20g(67m㏖)을 트리에틸포스파이트 100㎖에 섞고 180℃로 4시간 교반하였다. 상온으로 냉각한 후 용매를 감압 증류하였다. 메탄올로 결정화하여 목적 화합물 4-2 12.5g(75%)을 수득하였다.20 g (67 mmol) of the compound 4-1 was mixed with 100 ml of triethyl phosphite, and the mixture was stirred at 180 캜 for 4 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure. Crystallization with methanol gave 12.5 g (75%) of the desired compound 4-2.

(3) 화합물 4-3의 제조(3) Preparation of compound 4-3

화합물 4-2 4.7g(17.6m㏖), 구리 0.6g(8.8m㏖), 18-크라운-6 0.2g(0.9m㏖), K2CO3 4.8g(35.1m㏖) 및 1,2-디클로로벤젠 100㎖을 섞고 180℃에서 12시간 환류 교반시켰다. 상온으로 냉각시키고 감압 증류한 후 MC로 추출하고 증류수로 세척하였다. 무수 MgSO4로 건조하고 감압 증류하여 얻어진 잔사를 컬럼 분리하여 화합물 4-3 3.6(60%)을 수득하였다. (17.6 mmol) of Compound 4-2, 0.6 g (8.8 mmol) of copper, 0.2 g (0.9 mmol) of 18-crown-6, 4.8 g (35.1 mmol) of K 2 CO 3, 100 ml of dichlorobenzene were mixed and stirred under reflux at 180 占 폚 for 12 hours. Cooled to room temperature, distilled under reduced pressure, extracted with MC and washed with distilled water. Dried over anhydrous MgSO 4 and distilled under reduced pressure. The obtained residue was subjected to column separation to obtain Compound 4-3 3.6 (60%).

(4) 화합물 4-4의 제조(4) Preparation of compound 4-4

화합물 4-3 3g(7.1m㏖)을 DMF 40㎖에 녹이고, N-브로모숙신이미드 1.3g(7.1m㏖)을 천천히 첨가하였다. 이를 상온에서 하루 동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 4-4 2.7g(90%)을 수득하였다.3 g (7.1 mmol) of the compound 4-3 was dissolved in 40 ml of DMF, and 1.3 g (7.1 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 2.7 g (90%) of the target compound 4-4.

(5) 화합물 169의 제조(5) Preparation of compound 169

화합물 4-4 6.3g(15m㏖), 페닐보론산 2.2g(18m㏖), Pd(PPh3)4 1.7g (1.5m㏖) 및 K2CO3 4.1g (30m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100?에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 169, 5.5g(88%)을 수득하였다.Compound 4-4 6.3g (15m㏖), phenylboronic acid 2.2g (18m㏖), Pd (PPh 3) 4 1.7g (1.5m㏖) and K 2 CO 3 4.1g (30m㏖) toluene / ethanol / Dissolved in distilled water (100 ml / 25 ml / 20 ml), and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave the desired compound 169 (5.5 g, 88%).

합성예Synthetic example 5: 화합물 225의 제조 5: Preparation of compound 225

하기 반응식 5의 반응 경로를 거쳐 화합물 225을 합성하였다.Compound 225 was synthesized via the reaction path of Scheme 5 below.

<반응식 5><Reaction Scheme 5>

Figure 112013070990148-pat00049
Figure 112013070990148-pat00049

(1) 화합물 5-1의 제조(1) Preparation of Compound 5-1

9-브로모안트라센 20g(78m㏖), 2-메톡시나프탈렌보론산 18.8g(93m㏖), Pd(PPh3)4 7.8g(7.8m㏖) 및 K2CO3 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 5-1 23g(89%)을 수득하였다.9-bromo-anthracene 20g (78m㏖), 2- methoxy-naphthalene-boronic acid 18.8g (93m㏖), Pd (PPh 3) 4 7.8g (7.8m㏖) and K 2 CO 3 21.5g (156m㏖) Dissolved in toluene / ethanol / distilled water (390 ml / 97 ml / 78 ml), and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was then purified by column chromatography using dichloromethane and hexane as developing solvents to obtain 23 g (89%) of the target compound 5-1.

(2) 화합물 5-2의 제조(2) Preparation of Compound 5-2

화합물 5-1 23g(68.8m㏖)을 디클로로메탄 230㎖에 녹인 후 0?로 냉각하였다. 여기에 보론트리브로마이드 138㎖(138m㏖)를 천천히 첨가하였다. 온도를 상온으로 가온한 뒤 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 톨루엔 용매 하에서 교반한 뒤 여과하여 목적 화합물 5-2 38g(86%)을 수득하였다.23 g (68.8 mmol) of the compound 5-1 was dissolved in 230 ml of dichloromethane and then cooled to 0 ° C. 138 ml (138 mmol) of boron tribromide was slowly added thereto. The temperature was warmed to room temperature and then stirred. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The mixture was stirred in a toluene solvent and filtered to obtain 38 g (86%) of the target compound 5-2.

(3) 화합물 5-3의 제조(3) Preparation of compound 5-3

화합물 5-2 10g(22m㏖)을 디클로로메탄에 녹인 후 2,6-lutidine 3.9㎖(33m㏖)을 넣고 온도를 -30℃로 냉각한 뒤 교반하였다. 여기에 트리플루오로메탄설포닉 안하이드라이드 4.5㎖(27m㏖)을 천천히 첨가하였다. 온도를 0℃로 가온한 뒤 한 시간 동안 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 5-3 9.4g(95%)을 수득하였다.10 g (22 mmol) of the compound 5-2 was dissolved in dichloromethane, 3.9 ml (33 mmol) of 2,6-lutidine was added, and the mixture was cooled to -30 ° C and stirred. 4.5 ml (27 mmol) of trifluoromethanesulfonic anhydride was slowly added thereto. The temperature was raised to 0 &lt; 0 &gt; C and stirred for one hour. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 9.4 g (95%) of the desired compound 5-3.

(4) 화합물 5-4의 제조(4) Preparation of compound 5-4

화합물 5-3 9.4g(21m㏖), Pd(PPh3)2Cl2 2.9g(4.2m㏖), 리튬클로라이드 2.7g(63m㏖) 및 DBU 9.4㎖(63m㏖)을 디메틸포름이미드 150㎖에 녹인 후 140℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 3-4 4.7g(75%)을 수득하였다.Compound 5-3 9.4g (21m㏖), Pd ( PPh 3) 2 Cl 2 2.9g (4.2m㏖), lithium chloride 2.7g (63m㏖) and DBU 9.4㎖ (63m㏖) to dimethylformamide imide 150㎖ Followed by stirring at 140 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 4.7 g (75%) of the target compound 3-4.

(5) 화합물 5-5의 제조(5) Preparation of compound 5-5

화합물 5-4 4g(13.2m㏖)을 DMF 80㎖에 녹이고, N-브로모숙신이미드 2.4g(13.2m㏖)을 천천히 첨가하였다. 이를 상온에서 하루 동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 5-5 4.5g(90%)을 수득하였다.4 g (13.2 mmol) of the compound 5-4 was dissolved in 80 ml of DMF, and 2.4 g (13.2 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 4.5 g (90%) of the target compound 5-5.

(6) 화합물 225의 제조(6) Preparation of Compound 225

화합물 5-5 4.5g(11.8m㏖), 2-나프틸보론산 2.5g(14.2m㏖), Pd(PPh3)4 1.4g(1.2m㏖) 및 K2CO3 4.9g(35.4m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100?에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 최종 화합물인 화합물 225 4.3g(85%)을 수득하였다.Compound 5-5 4.5g (11.8m㏖), 2- naphthyl boronic acid 2.5g (14.2m㏖), Pd (PPh 3) 4 1.4g (1.2m㏖) and K 2 CO 3 4.9g (35.4m㏖ ) Was dissolved in toluene / ethanol / distilled water (100 ml / 25 ml / 20 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 4.3 g (85%) of 225 as the final compound.

합성예Synthetic example 6: 화합물 287의 제조 6: Preparation of compound 287

하기 반응식 6의 반응 경로를 거쳐 화합물 287을 합성하였다.Compound 287 was synthesized via the reaction path of Scheme 6 below.

<반응식 6><Reaction Scheme 6>

Figure 112013070990148-pat00050
Figure 112013070990148-pat00050

(1) 화합물 6-1의 제조(1) Preparation of Compound 6-1

화합물 9-브로모안트라센 20g(78m㏖), 1-메톡시-2-나프탈렌보론산 18.8g(93m㏖), Pd(PPh3)4 7.8g(7.8m㏖) 및 K2CO3, 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 6-1 23g(89%)을 수득하였다.Compound 9-bromo-anthracene 20g (78m㏖), 1- methoxy-2-naphthalene boronic acid 18.8g (93m㏖), Pd (PPh 3) 4 7.8g (7.8m㏖) and K 2 CO 3, 21.5g (156 mmol) was dissolved in toluene / ethanol / distilled water (390 ml / 97 ml / 78 ml), followed by stirring at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 23 g (89%) of the target compound 6-1.

(2) 화합물 6-2의 제조(2) Preparation of Compound 6-2

화합물 6-1 23g(68.8m㏖)을 디클로로메탄 230㎖에 녹인 후 0℃로 냉각하였다. 여기에 보론트리브로마이드 138㎖(138m㏖)를 천천히 첨가하였다. 온도를 상온으로 가온한 뒤 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 톨루엔 용매하에서 교반한 뒤 여과하여 목적 화합물 6-2 38g(86%)을 수득하였다.23 g (68.8 mmol) of the compound 6-1 was dissolved in 230 ml of dichloromethane and then cooled to 0 占 폚. 138 ml (138 mmol) of boron tribromide was slowly added thereto. The temperature was warmed to room temperature and then stirred. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under a toluene solvent and filtered to obtain 38 g (86%) of the target compound 6-2.

(3) 화합물 6-3의 제조(3) Preparation of Compound 6-3

화합물 6-2 10g(22m㏖)을 디클로로메탄에 녹인 후 2,6-루티딘(2,6-lutidine) 3.9㎖(33m㏖)을 넣고 온도를 -30℃로 냉각한 뒤 교반하였다. 여기에 트리플루오로메탄설포닉 안하이드라이드 4.5㎖(27m㏖)을 천천히 첨가하였다. 온도를 0℃로 가온한 뒤 한 시간 동안 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거 한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 6-3 9.4g(95%)을 수득하였다.10 g (22 mmol) of the compound 6-2 was dissolved in dichloromethane, and 3.9 ml (33 mmol) of 2,6-lutidine was added. The mixture was cooled to -30 ° C and stirred. 4.5 ml (27 mmol) of trifluoromethanesulfonic anhydride was slowly added thereto. The temperature was raised to 0 &lt; 0 &gt; C and stirred for one hour. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 9.4 g (95%) of the desired compound 6-3.

(4) 화합물 6-4의 제조(4) Preparation of compound 6-4

화합물 6-3 9.4g(21m㏖), Pd(PPh3)2Cl2 2.9g(4.2m㏖), 리튬클로라이드 2.7g(63m㏖), 및 DBU 9.4㎖(63m㏖)을 디메틸포름이미드 150㎖에 녹인 후 140℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 6-4 4.7g(75%)을 수득하였다.2.9 g (4.2 mmol) of Pd (PPh 3 ) 2 Cl 2 , 2.7 g (63 mmol) of lithium chloride and 9.4 ml (63 mmol) of DBU were added to a solution of dimethyl formamide 150 Ml, followed by stirring at 140 占 폚. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The residue was purified by column chromatography using dichloromethane and hexane as developing solvents to obtain 4.7 g (75%) of the target compound 6-4.

(5) 화합물 6-5의 제조(5) Preparation of Compound 6-5

화합물 6-4 4g(13.2m㏖)을 DMF 80㎖에 녹이고, N-브로모숙신이미드 2.4g(13.2m㏖)을 천천히 첨가하였다. 이를 상온에서 하루동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 6-5 4.5g(90%)을 수득하였다.4 g (13.2 mmol) of the compound 6-4 was dissolved in 80 ml of DMF, and 2.4 g (13.2 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 4.5 g (90%) of the target compound 6-5.

(6) 화합물 287의 제조(6) Preparation of Compound 287

화합물 6-5 4.5g(11.8m㏖), 2-나프틸보론산 2.5g(14.2m㏖), Pd(PPh3)4 1.4g(1.2m㏖), 및 K2CO3, 4.9g(35.4m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 287 4.3g(85%)을 수득하였다.Compound 6-5 4.5g (11.8m㏖), 2- naphthyl boronic acid 2.5g (14.2m㏖), Pd (PPh 3) 4 1.4g (1.2m㏖), and K 2 CO 3, 4.9g (35.4 mmol) were dissolved in toluene / ethanol / distilled water (100 ml / 25 ml / 20 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 4.3 g (85%) of the desired compound 287.

합성예Synthetic example 7: 화합물 337의 제조 7: Preparation of compound 337

하기 반응식 7의 반응 경로를 거쳐 화합물 337을 합성하였다.Compound 337 was synthesized via the reaction path of Scheme 7 below.

<반응식 7><Reaction Scheme 7>

Figure 112013070990148-pat00051
Figure 112013070990148-pat00051

(1) 화합물 7-1의 제조(1) Preparation of Compound 7-1

화합물 9-브로모-10메톡시-페난트렌(9-bromo-10-methoxy-Phenanthrene) 22.4g(78m㏖), 9-안트라센보론산 20.7g(93m㏖), Pd(PPh3)4 7.8g(7.8m㏖) 및 K2CO3, 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 7-1 6.9g(23%)을 수득하였다.Compound 9-bromo -10-methoxy-phenanthrene (9-bromo-10-methoxy -Phenanthrene) 22.4g (78m㏖), 9- anthracene boronic acid 20.7g (93m㏖), Pd (PPh 3) 4 7.8g (7.8 mmol) and K 2 CO 3 (21.5 g, 156 mmol) were dissolved in toluene / ethanol / distilled water (390 ml / 97 ml / 78 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 6.9 g (23%) of the target compound 7-1.

(2) 화합물 7-2의 제조(2) Preparation of Compound 7-2

화합물 7-1 26.5g(68.8m㏖)을 디클로로메탄 270㎖에 녹인 후 0℃로 냉각하였다. 여기에 보론트리브로마이드 138㎖(138m㏖)를 천천히 첨가하였다. 온도를 상온으로 가온한 뒤 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 톨루엔 용매하에서 교반한 뒤 여과하여 목적 화합물 7-2 19.1g(75%)을 수득하였다.26.5 g (68.8 mmol) of the compound 7-1 was dissolved in 270 ml of dichloromethane and then cooled to 0 占 폚. 138 ml (138 mmol) of boron tribromide was slowly added thereto. The temperature was warmed to room temperature and then stirred. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed by a rotary evaporator. The solvent was then stirred in toluene solvent and filtered to obtain 19.1 g (75%) of the target compound 7-2.

(3) 화합물 7-3의 제조(3) Preparation of Compound 7-3

화합물 7-2 8.1g(22m㏖)을 디클로로메탄에 녹인 후 2,6-루티딘(2,6-lutidine) 3.9㎖(33m㏖)을 넣고 온도를 -30℃로 냉각한 뒤 교반하였다. 여기에 트리플루오로메탄설포닉 안하이드라이드 4.5㎖(27m㏖)을 천천히 첨가하였다. 온도를 0℃로 가온한 뒤 한 시간 동안 교반하였다. 반응이 완결되면 증류수와 디클로로메탄으로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거 한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 7-3 9.1g(85%)을 수득하였다.8.1 g (22 mmol) of the compound 7-2 was dissolved in dichloromethane, and 3.9 ml (33 mmol) of 2,6-lutidine was added. The mixture was cooled to -30 캜 and stirred. 4.5 ml (27 mmol) of trifluoromethanesulfonic anhydride was slowly added thereto. The temperature was raised to 0 &lt; 0 &gt; C and stirred for one hour. When the reaction was complete, it was extracted with distilled water and dichloromethane. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 9.1 g (85%) of the desired compound 7-3.

(4) 화합물 7-4의 제조(4) Preparation of Compound 7-4

화합물 7-3 10.6g(21m㏖), Pd(PPh3)2Cl2 2.9g(4.2m㏖), 리튬클로라이드 2.7g(63m㏖), 및 DBU 9.4㎖(63m㏖)을 디메틸포름이미드 200㎖에 녹인 후 140℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 7-4 2.6g(35%)을 수득하였다.Compound 7-3 10.6g (21m㏖), Pd ( PPh 3) 2 Cl 2 2.9g (4.2m㏖), lithium chloride 2.7g (63m㏖), and DBU 9.4㎖ the mid-dimethylformamide to 200 a (63m㏖) Ml, followed by stirring at 140 占 폚. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 2.6 g (35%) of the desired compound 7-4.

(5) 화합물 7-5의 제조(5) Preparation of Compound 7-5

화합물 7-4 4.6g(13.2m㏖)을 DMF 100㎖에 녹이고, N-브로모숙신이미드 2.4g(13.2m㏖)을 천천히 첨가하였다. 이를 상온에서 17시간 동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 7-5 5.1g(90%)을 수득하였다.4.6 g (13.2 mmol) of the compound 7-4 was dissolved in 100 ml of DMF, and 2.4 g (13.2 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for 17 hours. When the reaction was completed, the reaction mixture was extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 5.1 g (90%) of the target compound 7-5.

(6) 화합물 337의 제조(6) Preparation of Compound 337

화합물 7-5 5.1g(11.8m㏖), 2-나프틸보론산 2.5g(14.2m㏖), Pd(PPh3)4 1.4g(1.2m㏖), 및 K2CO3, 4.9g(35.4m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 337 4.2g(75%)을 수득하였다.Compound 7-5 5.1g (11.8m㏖), 2- naphthyl boronic acid 2.5g (14.2m㏖), Pd (PPh 3) 4 1.4g (1.2m㏖), and K 2 CO 3, 4.9g (35.4 mmol) were dissolved in toluene / ethanol / distilled water (100 ml / 25 ml / 20 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 4.2 g (75%) of the desired compound 337.

합성예Synthetic example 8: 화합물 352의 제조 8: Preparation of compound 352

하기 반응식 8의 반응 경로를 거쳐 화합물 352를 합성하였다.Compound 352 was synthesized via the reaction path of Scheme 8 below.

<반응식 8><Reaction Scheme 8>

Figure 112013070990148-pat00052
Figure 112013070990148-pat00052

(1) 화합물 8-1의 제조(1) Preparation of Compound 8-1

화합물 1-3 10g(37.5m㏖), 아이오도벤젠 19.2g(94m㏖)을 톨루엔 100㎖에 녹였다. 여기에 트라이사이클로헥실포스핀 1.2g(0.4m㏖), Pd(OAc)2 0.9g(4m㏖), 포타시움 t-부톡사이드 리튬클로라이드 2.7g(63m㏖)을 12시간 이상 환류시켰다. 상온으로 냉각한 뒤 물을 붓고 유기물을 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 8-1 12.5g(80%)을 수득하였다.10 g (37.5 mmol) of Compound 1-3 and 19.2 g (94 mmol) of iodobenzene were dissolved in 100 ml of toluene. 1.2 g (0.4 mmol) of tricyclohexylphosphine, 0.9 g (4 mmol) of Pd (OAc) 2 and 2.7 g (63 mmol) of potassium t-butoxide lithium chloride were refluxed for 12 hours or more. After cooling to room temperature, water was poured and organic matter was extracted. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 12.5 g (80%) of the target compound 8-1.

(2) 화합물 8-2의 제조(2) Preparation of Compound 8-2

화합물 8-1 10g(20m㏖)을 DMF 150㎖에 녹이고, N-브로모숙신이미드 3.6g(20m㏖)을 천천히 첨가하였다. 이를 상온에서 하루 동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거하였다. 그 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 8-2 8.9g(90%)을 수득하였다.10 g (20 mmol) of the compound 8-1 was dissolved in 150 ml of DMF, and 3.6 g (20 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. Thereafter, purification was carried out by column chromatography using dichloromethane and hexane as eluent, to obtain 8.9 g (90%) of the desired compound 8-2.

(3) 화합물 352의 제조(3) Preparation of compound 352

화합물 8-2 8g(16.1m㏖), 2-나프틸-4-페닐보론산 4.8g(19.3m㏖), Pd(PPh3)4 1.8g(1.6m㏖) 및 K2CO3 4.5g(32.2m㏖)을 톨루엔/에탄올/증류수 160㎖/32㎖/32㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기물을 무수 MgSO4로 건조시킨 후 회전증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 최종 화합물인 화합물 352 8.5g(85%)을 수득하였다.Compound 8-2 8g (16.1m㏖), 2- naphthyl, 4-phenyl-boronic acid 4.8g (19.3m㏖), Pd (PPh 3) 4 1.8g (1.6m㏖) and K 2 CO 3 4.5g ( 32.2 mmol) was dissolved in toluene / ethanol / distilled water (160 ml / 32 ml / 32 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was then purified by column chromatography using dichloromethane and hexane as developing solvents to obtain 8.5 g (85%) of Compound 352 as a final compound.

합성예Synthetic example 9: 화합물 393의 제조 9: Preparation of compound 393

하기 반응식 9의 반응 경로를 거쳐 화합물 393을 합성하였다.Compound 393 was synthesized via the reaction path of Scheme 9 below.

<반응식 9><Reaction Scheme 9>

Figure 112013070990148-pat00053
Figure 112013070990148-pat00053

(1) 화합물 9-1의 제조 (1) Production of Compound 9-1

화합물 9-브로모안트라센 10g(39mol), (2-포밀나프탈렌-1-일)보론산((2-formylnaphthalen-1-yl)boronic acid) 9.4g(47m㏖), Pd(PPh3)4 4.5g(3.9m㏖) 및 K2CO3 10.5g(76m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 9-1 5.8g(45%)을 수득하였다.Compound 9-bromo-anthracene 10g (39mol), (2- formyl-1-yl) boronic acid ((2-formylnaphthalen-1- yl) boronic acid) 9.4g (47m㏖), Pd (PPh 3) 4 4.5 g (3.9 mmol) of K 2 CO 3 and 10.5 g (76 mmol) of K 2 CO 3 were dissolved in toluene / ethanol / distilled water 200 ml / 50 ml / 40 ml and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 5.8 g (45%) of the desired compound 9-1.

(2) 화합물 9-2의 제조(2) Preparation of Compound 9-2

IPy2BF4 21g(56m㏖)을 디클로로메탄에 녹인 후 -78℃로 냉각하였다. HBF4 18.2g(112m㏖)을 가한 뒤 10분 동안 -78℃에서 교반하였다. 고체를 여과 후 여액을 -60℃로 냉각한 뒤 9-1 5.8g(17.5m㏖)을 천천히 첨가하였다. 반응이 완결되면 얼음물로 반응 종결 후 유기층을 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 9-2 3.0g(52%)을 수득하였다.21 g (56 mmol) of IPy 2 BF 4 was dissolved in dichloromethane and cooled to -78 ° C. 18.2 g (112 mmol) of HBF 4 was added, and the mixture was stirred at -78 캜 for 10 minutes. After filtering the solid, the filtrate was cooled to -60 DEG C and then 5.8 g (17.5 mmol) of 9-1 was added slowly. When the reaction was completed, the organic layer was extracted with ice water after completion of the reaction. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 3.0 g (52%) of the desired compound 9-2.

(3) 화합물 9-3의 제조(3) Preparation of Compound 9-3

화합물 9-2 5.6g(17m㏖)을 다이에틸이써 100㎖에 녹이고, AlCl3 2.7g(20.4m㏖)을 천천히 첨가하였다. 이를 15분 동안 교반 한 후, 0℃로 냉각하고 리튬알루미늄하이드라이드(LAH) 1g(26m㏖)를 천천히 첨가하였다. 이를 1시간 동안 환류 교반한 후 반응이 완결되면 상온으로 천천히 냉각하고, 여기에 EA를 거품이 일어나지 않을 때까지 천천히 넣어주었다. 그 후, 6N HCl 20㎖을 넣어주고, 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디틀로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 화합물 9-3 4.3g(80%)을 수득하였다. 5.6 g (17 mmol) of the compound 9-2 was dissolved in 100 ml of diethyl ether, and 2.7 g (20.4 mmol) of AlCl 3 was added slowly. It was stirred for 15 minutes, then cooled to 0 ° C and 1 g (26 mmol) of lithium aluminum hydride (LAH) was slowly added. This was refluxed for 1 hour. After the reaction was completed, the reaction mixture was slowly cooled to room temperature, and EA was slowly added thereto until no bubbles were formed. Then, 20 ml of 6N HCl was added thereto, and the mixture was extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure to give 4.3 g (80%) of compound 9-3 as a developing solvent.

(4) 화합물 9-4의 제조(4) Preparation of Compound 9-4

화합물 9-3 4.7g(15m㏖)을 DMSO 40㎖에 녹인 다음, 상온에서 소듐 tert-부톡사이드 10.7g(112m㏖)를 넣어주고 70℃에서 15분간 교반하였다. 여기에 요오드화벤젠 26.9g(132m㏖)을 천천히 첨가하고 1시간 더 교반하였다. 반응이 완결되면 상온에서 냉각하고 증류수를 넣어 20분간 교반하였다. 이때, 고체가 생성되는데 이를 여과하고, 얻어진 고체를 에탄올과 아세톤으로 재결정하여 화합물 9-4 4.2g(60%)을 수득하였다.4.7 g (15 mmol) of the compound 9-3 was dissolved in 40 ml of DMSO, 10.7 g (112 mmol) of sodium tert-butoxide was added at room temperature, and the mixture was stirred at 70 ° C for 15 minutes. 26.9 g (132 mmol) of benzene iodide was slowly added thereto, and the mixture was further stirred for 1 hour. When the reaction was completed, the reaction mixture was cooled at room temperature, and distilled water was added thereto, followed by stirring for 20 minutes. At this time, a solid was formed, which was filtered, and the resulting solid was recrystallized from ethanol and acetone to obtain 4.2 g (60%) of Compound 9-4.

(5) 화합물 9-5의 제조(5) Preparation of Compound 9-5

화합물 9-4 4.1g(8.8m㏖)을 DMF 30㎖에 녹이고, N-브로모숙신이미드 1.6g(8.8m㏖)을 천천히 첨가하였다. 이를 상온에서 하루동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 9-5 4.3g(90%)을 수득하였다.4.1 g (8.8 mmol) of Compound 9-4 was dissolved in 30 ml of DMF, and 1.6 g (8.8 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 4.3 g (90%) of the target compound 9-5.

(6) 화합물 393의 제조(6) Preparation of compound 393

화합물 9-5 14.7g(26.8m㏖), (9-phenyl-9H-carbazol-3-yl)boronic acid 9.2g(32m㏖), Pd(PPh3)4 4.5g(3.1m㏖) 및 K2CO3 7.4g(53.6m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 393 13.3g(70%)을 수득하였다.Compound 9-5 14.7g (26.8m㏖), (9 -phenyl-9H-carbazol-3-yl) boronic acid 9.2g (32m㏖), Pd (PPh 3) 4 4.5g (3.1m㏖) and K 2 7.4 g (53.6 mmol) of CO 3 was dissolved in toluene / ethanol / distilled water (200 ml / 50 ml / 40 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and purified by column chromatography using dichloromethane and hexane as eluent to obtain 13.3 g (70%) of the desired compound 393.

합성예Synthetic example 10: 화합물 414의 제조 10: Preparation of compound 414

하기 반응식 10의 반응 경로를 거쳐 화합물 414을 합성하였다.Compound 414 was synthesized via the reaction path of Scheme 10 below.

<반응식 10><Reaction formula 10>

Figure 112013070990148-pat00054
Figure 112013070990148-pat00054

(1) 화합물 10-1의 제조 (1) Preparation of Compound 10-1

화합물 9-브로모안트라센 10g(39mol), (1-formylnaphthalen-2-yl)boronic acid 9.4g(47m㏖), Pd(PPh3)4 4.5g(3.9m㏖) 및 K2CO3 10.5g(76m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 10-1 1.9g(15%)을 수득하였다.Compound 9-bromo-anthracene 10g (39mol), (1- formylnaphthalen-2-yl) boronic acid 9.4g (47m㏖), Pd (PPh 3) 4 4.5g (3.9m㏖) and K 2 CO 3 10.5g ( 76 mmol) was dissolved in toluene / ethanol / distilled water (200 ml / 50 ml / 40 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 1.9 g (15%) of the target compound 10-1.

(2) 화합물 10-2의 제조(2) Preparation of Compound 10-2

IPy2BF4 21g(56m㏖)을 디클로로메탄에 녹인 후 -78℃로 냉각하였다. HBF4 18.2g(112m㏖)을 가한 뒤 10분 동안 -78℃에서 교반하였다. 고체를 여과 후 여액을 -60℃로 냉각 한 뒤 10-1 5.8g(17.5m㏖)을 천천히 첨가하였다. 21 g (56 mmol) of IPy 2 BF 4 was dissolved in dichloromethane and cooled to -78 ° C. 18.2 g (112 mmol) of HBF 4 was added, and the mixture was stirred at -78 캜 for 10 minutes. After filtering the solid, the filtrate was cooled to -60 DEG C and then 5.8 g (17.5 mmol) of 10-1 was slowly added.

반응이 완결되면 얼음물로 반응 종결 후 유기층을 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 10-2 3.0g(52%)을 수득하였다.When the reaction was completed, the organic layer was extracted with ice water after completion of the reaction. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 3.0 g (52%) of the target compound 10-2.

(3) 화합물 10-3의 제조(3) Preparation of Compound 10-3

화합물 10-2 5.6g(17m㏖)을 다이에틸이써 100㎖에 녹이고, AlCl3 2.7g(20.4m㏖)을 천천히 첨가하였다. 이를 15분 동안 교반 한 후, 0℃로 냉각하고 리튬알루미늄하이드라이드(LAH) 1g(26m㏖)를 천천히 첨가하였다. 이를 1시간 동안 환류 교반한 후 반응이 완결되면 상온으로 천천히 냉각하고, 여기에 EA를 거품이 일어나지 않을 때까지 천천히 넣어주었다. 그 후, 6N HCl 20㎖을 넣어주고, 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디틀로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 화합물 10-3 3.8g(70%)을 수득하였다. 5.6 g (17 mmol) of the compound 10-2 was dissolved in 100 ml of diethyl ether, and 2.7 g (20.4 mmol) of AlCl 3 was slowly added. It was stirred for 15 minutes, then cooled to 0 ° C and 1 g (26 mmol) of lithium aluminum hydride (LAH) was slowly added. This was refluxed for 1 hour. After the reaction was completed, the reaction mixture was slowly cooled to room temperature, and EA was slowly added thereto until no bubbles were formed. Then, 20 ml of 6N HCl was added thereto, and the mixture was extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure to give 3.8 g (70%) of compound 10-3 as a developing solvent.

(4) 화합물 10-4의 제조(4) Preparation of compound 10-4

화합물 10-3 4.7g(15m㏖)을 DMSO 40㎖에 녹인 다음, 상온에서 소듐 tert-부톡사이드 10.7g(112m㏖)를 넣어주고 70℃에서 15분간 교반하였다. 여기에 요오드화벤젠 26.9g(132m㏖)을 천천히 첨가하고 1시간 더 교반하였다. 반응이 완결되면 상온에서 냉각하고 증류수를 넣어 20분간 교반하였다. 이때, 고체가 생성되는데 이를 여과하고, 얻어진 고체를 에탄올과 아세톤으로 재결정하여 화합물 10-4 4.2g(60%)을 수득하였다.After dissolving 4.7 g (15 mmol) of the compound 10-3 in 40 ml of DMSO, 10.7 g (112 mmol) of sodium tert-butoxide was added at room temperature, and the mixture was stirred at 70 캜 for 15 minutes. 26.9 g (132 mmol) of benzene iodide was slowly added thereto, and the mixture was further stirred for 1 hour. When the reaction was completed, the reaction mixture was cooled at room temperature, and distilled water was added thereto, followed by stirring for 20 minutes. At this time, a solid was formed, which was filtered, and the obtained solid was recrystallized from ethanol and acetone to obtain 4.2 g (60%) of Compound 10-4.

(5) 화합물 10-5의 제조(5) Preparation of Compound 10-5

화합물 10-4 4.1g(8.8m㏖)을 DMF 30㎖에 녹이고, N-브로모숙신이미드 1.6g(8.8m㏖)을 천천히 첨가하였다. 이를 상온에서 하루동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 10-5 4.3g(90%)을 수득하였다.4.1 g (8.8 mmol) of Compound 10-4 was dissolved in 30 ml of DMF, and 1.6 g (8.8 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as developing solvents to obtain 4.3 g (90%) of the target compound 10-5.

(6) 화합물 414의 제조(6) Preparation of compound 414

화합물 10-5 14.7g(26.8m㏖), 디베조티오펜-2-닐 보론산 7.3g(32m㏖), Pd(PPh3)4 4.5g(3.1m㏖) 및 K2CO3 7.4g(53.6m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 414 13.3g(70%)을 수득하였다.Compound 10-5 14.7g (26.8m㏖), dibe joti carbonyl-2-boronic acid 7.3g (32m㏖), Pd (PPh 3) 4 4.5g (3.1m㏖) and K 2 CO 3 7.4g (53.6 ml) was dissolved in toluene / ethanol / distilled water (200 ml / 50 ml / 40 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was then purified by column chromatography using dichloromethane and hexane as eluent to obtain 13.3 g (70%) of the desired compound 414.

합성예Synthetic example 11: 화합물 472의 제조 11: Preparation of compound 472

하기 반응식 11의 반응 경로를 거쳐 화합물 472을 합성하였다.Compound 472 was synthesized via the reaction path of Scheme 11 below.

<반응식 11><Reaction Scheme 11>

Figure 112013070990148-pat00055
Figure 112013070990148-pat00055

(1) 화합물 11-1의 제조 (1) Production of Compound 11-1

화합물 10-브로모-9-페난트렌카르복알데하이드(10-Bromo-9-phenanthrenecarboxaldehyde) 11.1g(39mol), 9-안트라센보론산9.4g(47m㏖), Pd(PPh3)4 4.5g(3.9m㏖) 및 K2CO3 10.5g(76m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 11-1 3.7g(25%)을 수득하였다.Compound 10-Bromo-9-phenanthrene carboxylic aldehyde (10-Bromo-9-phenanthrenecarboxaldehyde ) 11.1g (39mol), 9- anthracene boronic acid 9.4g (47m㏖), Pd (PPh 3) 4 4.5g (3.9 and 10.5 g (76 mmol) of K 2 CO 3 were dissolved in toluene / ethanol / distilled water (200 ml / 50 ml / 40 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 3.7 g (25%) of the desired compound 11-1.

(2) 화합물 11-2의 제조(2) Preparation of Compound 11-2

IPy2BF4 21g(56m㏖)을 디클로로메탄에 녹인 후 -78℃로 냉각하였다. HBF4 18.2g(112m㏖)을 가한 뒤 10분 동안 -78℃에서 교반하였다. 고체를 여과 후 여액을 -60℃로 냉각 한 뒤 11-1 6.7g(17.5m㏖)을 천천히 첨가하였다. 반응이 완결되면 얼음물로 반응 종결 후 유기층을 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 11-2 3.5g(52%)을 수득하였다.21 g (56 mmol) of IPy 2 BF 4 was dissolved in dichloromethane and cooled to -78 ° C. 18.2 g (112 mmol) of HBF 4 was added, and the mixture was stirred at -78 캜 for 10 minutes. After filtering the solid, the filtrate was cooled to -60 DEG C and then 11-1 (6.7 g, 17.5 mmol) was added slowly. When the reaction was completed, the organic layer was extracted with ice water after completion of the reaction. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 3.5 g (52%) of the desired compound 11-2.

(3) 화합물 11-3의 제조(3) Production of Compound 11-3

화합물 11-2 6.5g(17m㏖)을 다이에틸이써 100㎖에 녹이고, AlCl3 2.7g(20.4m㏖)을 천천히 첨가하였다. 이를 15분 동안 교반 한 후, 0℃로 냉각하고 리튬알루미늄하이드라이드(LAH) 1g(26m㏖)를 천천히 첨가하였다. 이를 1시간 동안 환류 교반한 후 반응이 완결되면 상온으로 천천히 냉각하고, 여기에 EA를 거품이 일어나지 않을 때까지 천천히 넣어주었다. 그 후, 6N HCl 20㎖을 넣어주고, 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디틀로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 화합물 11-3 4.4g(70%)을 수득하였다. 6.5 g (17 mmol) of the compound 11-2 was dissolved in 100 ml of diethyl ether, and 2.7 g (20.4 mmol) of AlCl 3 was added slowly. It was stirred for 15 minutes, then cooled to 0 ° C and 1 g (26 mmol) of lithium aluminum hydride (LAH) was slowly added. This was refluxed for 1 hour. After the reaction was completed, the reaction mixture was slowly cooled to room temperature, and EA was slowly added thereto until no bubbles were formed. Then, 20 ml of 6N HCl was added thereto, and the mixture was extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 4.4 g (70%) of compound 11-3.

(4) 화합물 11-4의 제조(4) Preparation of compound 11-4

화합물 11-3 5.5g(15m㏖)을 DMSO 40㎖에 녹인 다음, 상온에서 소듐 tert-부톡사이드 10.7g(112m㏖)를 넣어주고 70℃에서 15분간 교반하였다. 여기에 요오드화벤젠 26.9g(132m㏖)을 천천히 첨가하고 1시간 더 교반하였다. 반응이 완결되면 상온에서 냉각하고 증류수를 넣어 20분간 교반하였다. 이때, 고체가 생성되는데 이를 여과하고, 얻어진 고체를 에탄올과 아세톤으로 재결정하여 화합물 11-4 4.7g(60%)을 수득하였다.5.5 g (15 mmol) of the compound 11-3 was dissolved in 40 ml of DMSO, 10.7 g (112 mmol) of sodium tert-butoxide was added at room temperature, and the mixture was stirred at 70 ° C for 15 minutes. 26.9 g (132 mmol) of benzene iodide was slowly added thereto, and the mixture was further stirred for 1 hour. When the reaction was completed, the reaction mixture was cooled at room temperature, and distilled water was added thereto, followed by stirring for 20 minutes. At this time, a solid was formed. The solid was filtered and the obtained solid was recrystallized from ethanol and acetone to obtain 4.7 g (60%) of Compound 11-4.

(5) 화합물 11-5의 제조(5) Preparation of compound 11-5

화합물 11-4 4.6g(8.8m㏖)을 DMF 30㎖에 녹이고, N-브로모숙신이미드 1.6g(8.8m㏖)을 천천히 첨가하였다. 이를 상온에서 하루동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 11-5 4.7g(90%)을 수득하였다.4.6 g (8.8 mmol) of the compound 11-4 was dissolved in 30 ml of DMF, and 1.6 g (8.8 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. The residue was purified by column chromatography using dichloromethane and hexane as developing solvents to obtain 4.7 g (90%) of the desired compound 11-5.

(6) 화합물 472의 제조(6) Preparation of compound 472

화합물 11-5 16g(26.8m㏖), 9-페닐-9H-카바졸-3-일)보론산((9-phenyl-9H-carbazol-3-yl)boronic acid) 9.2g(32m㏖), Pd(PPh3)4 4.5g(3.1m㏖) 및 K2CO3 7.4g(53.6m㏖)을 톨루엔/에탄올/증류수 200㎖/50㎖/40㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 472 11.4g(60%)을 수득하였다.9.2 g (32 mmol) of Compound 11-5, 16 g (26.8 mmol) of 9-phenyl-9H-carbazol-3-yl) boronic acid, Pd (PPh 3) was stirred at 4 4.5g (3.1m㏖) and K 2 CO 3 7.4g following 100 ℃ (53.6m㏖) dissolved in a toluene / ethanol / distilled water 200㎖ / 50㎖ / 40㎖. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 11.4 g (60%) of the target compound 472.

합성예Synthetic example 12: 화합물 509의 제조 12: Preparation of compound 509

하기 반응식 12의 반응 경로를 거쳐 화합물 509을 합성하였다.Compound 509 was synthesized via the reaction path of Scheme 12 below.

<반응식 12><Reaction Scheme 12>

Figure 112013070990148-pat00056
Figure 112013070990148-pat00056

(1) 화합물 12-1의 제조(1) Preparation of Compound 12-1

화합물 9-브로모안트라센 20g(78m㏖), (2-나이트로나프탈렌-1-일)보론산 ((2-nitronaphthalen-1-yl)boronic acid) 20g(93m㏖), Pd(PPh3)4 9g(7.8m㏖) 및 K2CO3 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 12-1 13.6g(50%)을 수득하였다.Compound 9-bromo-anthracene 20g (78m㏖), (2-nitro-1-yl) boronic acid ((2-nitronaphthalen-1- yl) boronic acid) 20g (93m㏖), Pd (PPh 3) 4 9 g (7.8 mmol) of K 2 CO 3 and 21.5 g (156 mmol) of K 2 CO 3 were dissolved in 390 ml / 97 ml / 78 ml of toluene / ethanol / distilled water and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 13.6 g (50%) of the target compound 12-1.

(2) 화합물 12-2의 제조(2) Preparation of Compound 12-2

화합물 12-1 23.4g(67m㏖)을 트리에틸포스파이트 100㎖에 섞고 180℃로 17시간 교반하였다. 상온으로 냉각한 후 용매를 감압 증류하였다. 메탄올로 결정화하여 목적 화합물 12-2 8.5g(40%)을 수득하였다.23.4 g (67 mmol) of the compound 12-1 was added to 100 ml of triethyl phosphite, and the mixture was stirred at 180 占 폚 for 17 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure. Crystallization with methanol gave 8.5 g (40%) of the desired compound 12-2.

(3) 화합물 12-3의 제조(3) Preparation of compound 12-3

화합물 12-2 5.6g(17.6m㏖), 구리 0.6g(8.8m㏖), 18-크라운-6 0.2g(0.9m㏖), K2CO3 4.8g(35.1m㏖) 및 1,2-디클로로벤젠 100㎖을 섞고 180℃에서 17시간 환류 교반시켰다. 상온으로 냉각시키고 감압 증류한 후 MC로 추출하고 증류수로 세척하였다. 무수 MgSO4로 건조하고 감압 증류하여 얻어진 잔사를 컬럼 분리하여 화합물 12-3 4.2g(60%)을 수득하였다.Compound 12-2 5.6g (17.6m㏖), copper 0.6g (8.8m㏖), 18- crown -6 0.2g (0.9m㏖), K 2 CO 3 4.8g (35.1m㏖) and 1,2 100 ml of dichlorobenzene were mixed, and the mixture was refluxed and stirred at 180 占 폚 for 17 hours. Cooled to room temperature, distilled under reduced pressure, extracted with MC and washed with distilled water. Dried over anhydrous MgSO 4 and distilled under reduced pressure. The resulting residue was subjected to column separation to obtain 4.2 g (60%) of Compound 12-3.

(4) 화합물 12-4의 제조(4) Preparation of compound 12-4

화합물 12-3 2.8g(7.1m㏖)을 DMF 40㎖에 녹이고, N-브로모숙신이미드 1.3g(7.1m㏖)을 천천히 첨가하였다. 이를 상온에서 하루동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 12-4 3.0g(90%)을 수득하였다.2.8 g (7.1 mmol) of the compound 12-3 was dissolved in 40 ml of DMF, and 1.3 g (7.1 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 3.0 g (90%) of the target compound 12-4.

(5) 화합물 509의 제조(5) Preparation of Compound 509

화합물 12-4 7.1g(15m㏖), 2-나프탈렌보론산 3.1g(18m㏖), Pd(PPh3)4 1.7g(1.5m㏖), 및 K2CO3, 4.1g(30m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 509 5g(65%)을 수득하였다.Compound 12-4 7.1g (15m㏖), 2- naphthalenesulfonic acid 3.1g (18m㏖), Pd (PPh 3) 4 1.7g (1.5m㏖), and K 2 CO 3, 4.1g (30m㏖ ) the Dissolved in toluene / ethanol / distilled water 100 ml / 25 ml / 20 ml, and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 5 g (65%) of the target compound 509.

합성예Synthetic example 13: 화합물 510의 제조 13: Preparation of compound 510

하기 반응식 13의 반응 경로를 거쳐 화합물 510을 합성하였다.Compound 510 was synthesized via the reaction path of Scheme 13 below.

<반응식 13><Reaction Scheme 13>

Figure 112013070990148-pat00057
Figure 112013070990148-pat00057

(1) 화합물 13-1의 제조(1) Preparation of Compound 13-1

화합물 9-bromo-10-nitrophenanthrene 23.6g(78m㏖), (2-phenylanthracen-9-yl)boronic acid 27.7g(93m㏖), Pd(PPh3)4 9g(7.8m㏖) 및 K2CO3 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 13-1 3.7g(10%)을 수득하였다.Compound 9-bromo-10-nitrophenanthrene 23.6g (78m㏖), (2-phenylanthracen-9-yl) boronic acid 27.7g (93m㏖), Pd (PPh 3) 4 9g (7.8m㏖) and K 2 CO 3 21.5 g (156 mmol) of the compound was dissolved in 390 ml / 97 ml / 78 ml of toluene / ethanol / distilled water, followed by stirring at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 3.7 g (10%) of the desired compound 13-1.

(2) 화합물 13-2의 제조(2) Preparation of Compound 13-2

화합물 13-1 31.7g(67m㏖)을 트리에틸포스파이트 320㎖에 섞고 180℃로 17시간 교반하였다. 상온으로 냉각한 후 용매를 감압 증류하였다. 에탄올로 결정화하여 목적 화합물 13-2 17.8g(60%)을 수득하였다.31.7 g (67 mmol) of the compound 13-1 was mixed with 320 ml of triethyl phosphite, and the mixture was stirred at 180 캜 for 17 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure. Crystallization with ethanol gave 17.8 g (60%) of the desired compound 13-2.

(3) 화합물 13-3의 제조(3) Production of compound 13-3

화합물 13-2 7.8g(17.6m㏖), 구리 0.6g(8.8m㏖), 18-크라운-6 0.2g(0.9m㏖), K2CO3 4.8g(35.1m㏖) 및 1,2-디클로로벤젠 100㎖을 섞고 180℃에서 17시간 환류 교반시켰다. 상온으로 냉각시키고 감압 증류 한 후 MC로 추출하고 증류수로 세척하였다. 무수 MgSO4로 건조하고 감압 증류하여 얻어진 잔사를 컬럼 분리하여 화합물 13-3 4.6g(50%)을 수득하였다.Compound 13-2 7.8g (17.6m㏖), copper 0.6g (8.8m㏖), 18- crown -6 0.2g (0.9m㏖), K 2 CO 3 4.8g (35.1m㏖) and 1,2 100 ml of dichlorobenzene were mixed, and the mixture was refluxed and stirred at 180 占 폚 for 17 hours. Cooled to room temperature, distilled under reduced pressure, extracted with MC and washed with distilled water. Dried over anhydrous MgSO 4 and distilled under reduced pressure. The obtained residue was subjected to column separation to obtain 4.6 g (50%) of Compound 13-3.

(4) 화합물 13-4의 제조(4) Preparation of compound 13-4

화합물 13-3 3.7g(7.1m㏖)을 DMF 40㎖에 녹이고, N-브로모숙신이미드 1.3g(7.1m㏖)을 천천히 첨가하였다. 이를 상온에서 하루동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 13-4 3.6g(85%)을 수득하였다.3.7 g (7.1 mmol) of the compound 13-3 was dissolved in 40 ml of DMF, and 1.3 g (7.1 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 3.6 g (85%) of the target compound 13-4.

(5) 화합물 510의 제조(5) Preparation of compound 510

화합물 13-4 9g(15m㏖), [1,1'-biphenyl]-3-ylboronic acid 3.6g(18m㏖), Pd(PPh3)4 1.7g(1.5m㏖), 및 K2CO3 4.1g(30m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 510 4.8g(50%)을 수득하였다.Compound 13-4 9g (15m㏖), [1,1' -biphenyl] -3-ylboronic acid 3.6g (18m㏖), Pd (PPh 3) 4 1.7g (1.5m㏖), and K 2 CO 3 4.1 g (30 mmol) was dissolved in toluene / ethanol / distilled water (100 ml / 25 ml / 20 ml) and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and then purified by column chromatography using dichloromethane and hexane as eluent to obtain 4.8 g (50%) of the desired compound 510.

합성예Synthetic example 14: 화합물 531의 제조 14: Preparation of compound 531

하기 반응식 14의 반응 경로를 거쳐 화합물 531을 합성하였다.Compound 531 was synthesized via the reaction path of Scheme 14 below.

<반응식 14><Reaction Scheme 14>

Figure 112013070990148-pat00058
Figure 112013070990148-pat00058

(1) 화합물 14-1의 제조(1) Preparation of Compound 14-1

화합물 9-브로모안트라센 20g(78m㏖), (1-나이트로나프탈렌-2-일)보론산 ((1-nitronaphthalen-2-yl)boronic acid) 20g(93m㏖), Pd(PPh3)4 9g(7.8m㏖) 및 K2CO3 21.5g(156m㏖)을 톨루엔/에탄올/증류수 390㎖/97㎖/78㎖에 녹인 후 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 14-1 8.2g(30%)을 수득하였다.Compound 9-bromo-anthracene 20g (78m㏖), (1-nitro-naphthalene-2-yl) boronic acid ((1-nitronaphthalen-2- yl) boronic acid) 20g (93m㏖), Pd (PPh 3) 4 9 g (7.8 mmol) of K 2 CO 3 and 21.5 g (156 mmol) of K 2 CO 3 were dissolved in 390 ml / 97 ml / 78 ml of toluene / ethanol / distilled water and stirred at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed by a rotary evaporator, and the residue was purified by column chromatography using dichloromethane and hexane as eluent to obtain 8.2 g (30%) of the target compound 14-1.

(2) 화합물 14-2의 제조(2) Preparation of Compound 14-2

화합물 14-1 23.4g(67m㏖)을 트리에틸포스파이트 100㎖에 섞고 180℃로 17시간 교반하였다. 상온으로 냉각한 후 용매를 감압 증류하였다. 에탄올로 결정화하여 목적 화합물 14-2 12.8g(60%)을 수득하였다.23.4 g (67 mmol) of the compound 14-1 was mixed with 100 ml of triethyl phosphite, and the mixture was stirred at 180 占 폚 for 17 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure. Crystallization with ethanol gave 12.8 g (60%) of the desired compound 14-2.

(3) 화합물 14-3의 제조(3) Preparation of Compound 14-3

화합물 14-2 5.6g(17.6m㏖), 구리 0.6g(8.8m㏖), 18-크라운-6 0.2g(0.9m㏖), K2CO3 4.8g(35.1m㏖) 및 1,2-디클로로벤젠 100㎖을 섞고 180℃에서 17시간 환류 교반시켰다. 상온으로 냉각시키고 감압 증류한 후 MC로 추출하고 증류수로 세척하였다. 무수 MgSO4로 건조하고 감압 증류하여 얻어진 잔사를 컬럼 분리하여 화합물 14-3 4.2g(60%)을 수득하였다.(17.6 mmol) of Compound 14-2, 0.6 g (8.8 mmol) of copper, 0.2 g (0.9 mmol) of 18-crown-6, 4.8 g (35.1 mmol) of K 2 CO 3, 100 ml of dichlorobenzene were mixed, and the mixture was refluxed and stirred at 180 占 폚 for 17 hours. Cooled to room temperature, distilled under reduced pressure, extracted with MC and washed with distilled water. Dried over anhydrous MgSO 4 , distilled under reduced pressure, and the obtained residue was subjected to column separation to obtain 4.2 g (60%) of Compound 14-3.

(4) 화합물 14-4의 제조(4) Preparation of compound 14-4

화합물 14-3 2.8g(7.1m㏖)을 DMF 40㎖에 녹이고, N-브로모숙신이미드 1.3g(7.1m㏖)을 천천히 첨가하였다. 이를 상온에서 하루동안 교반한 후 반응이 완결되면 증류수와 에틸아세테이트로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼 크로마토그래피로 정제하여 목적 화합물 14-4 3.0g(90%)을 수득하였다.2.8 g (7.1 mmol) of the compound 14-3 was dissolved in 40 ml of DMF, and 1.3 g (7.1 mmol) of N-bromosuccinimide was added slowly. The reaction mixture was stirred at room temperature for one day and then extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 3.0 g (90%) of the target compound 14-4.

(5) 화합물 531의 제조(5) Preparation of compound 531

화합물 14-4 7.1g(15m㏖), 2-나프탈렌보론산 3.1g(18m㏖), Pd(PPh3)4 1.7g(1.5m㏖), 및 K2CO3 4.1g(30m㏖)을 톨루엔/에탄올/증류수 100㎖/25㎖/20㎖에 녹인 다음 100℃에서 교반하였다. 반응이 완결되면 증류수와 EA로 추출하였다. 유기층을 무수 MgSO4로 건조시킨 후 회전 증발기로 용매를 제거한 후 디클로로메탄과 헥산을 전개용매로 이용하여 컬럼크로마토그래피로 정제하여 목적 화합물 531 3.8g(50%)을 수득하였다.
Compound 14-4 to 7.1g (15m㏖), 2- naphthalenesulfonic acid 3.1g (18m㏖), Pd (PPh 3) 4 1.7g (1.5m㏖), and K 2 CO 3 4.1g (30m㏖) toluene / Ethanol / distilled water (100 ml / 25 ml / 20 ml), followed by stirring at 100 ° C. After the reaction was completed, the reaction mixture was extracted with distilled water and EA. The organic layer was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator. Purification by column chromatography using dichloromethane and hexane as eluent gave 3.8 g (50%) of the target compound 531.

한편, 본 발명에 따른 화합물의 NMR값과 매스-스펙트럼(mass-spectrum data)를 하기 표 1에 기재하였다. 화합물 번호는 상기에 기재된 화합물의 번호와 동일하다.NMR and mass-spectrum data of the compounds according to the present invention are shown in Table 1 below. The compound numbers are the same as those of the compounds described above.

Figure 112013070990148-pat00059
Figure 112013070990148-pat00060
Figure 112013070990148-pat00059
Figure 112013070990148-pat00060

Figure 112013070990148-pat00061
Figure 112013070990148-pat00061

Figure 112013070990148-pat00062
Figure 112013070990148-pat00062

Figure 112013070990148-pat00063
Figure 112013070990148-pat00063

Figure 112013070990148-pat00064
Figure 112013070990148-pat00064

Figure 112013070990148-pat00065
Figure 112013070990148-pat00065

Figure 112013070990148-pat00066
Figure 112013070990148-pat00066

Figure 112013070990148-pat00067
Figure 112013070990148-pat00067

Figure 112013070990148-pat00068
Figure 112013070990148-pat00068

Figure 112013070990148-pat00069
Figure 112013070990148-pat00069

Figure 112013070990148-pat00070
Figure 112013070990148-pat00070

Figure 112013070990148-pat00071
Figure 112013070990148-pat00071

Figure 112013070990148-pat00072
Figure 112013070990148-pat00072

Figure 112013070990148-pat00073
Figure 112013070990148-pat00073

<< 실시예Example 1> 본 발명의 화합물을 이용한  1 > Using the compound of the present invention OLEDOLED 의 제작Production

우선, OLED용 글래스(삼성-코닝사 제조)(1)로부터 얻어진 투명전극 ITO 박막(2)을, 트리클로로에틸렌, 아세톤, 에탄올, 증류수를 순차적으로 사용하여 초음파 세척을 실시한 후, 이소프로판올에 넣어 보관한 후 사용하였다.First, a transparent electrode ITO thin film 2 obtained from an OLED glass (manufactured by Samsung Corning) (1) was subjected to ultrasonic cleaning using trichlorethylene, acetone, ethanol and distilled water sequentially, and then stored in isopropanol Respectively.

다음으로, 진공 증착 장비의 기판 폴더에 ITO 기판을 설치하고, 진공 증착 장비 내의 셀에 하기 구조의 N,N'-비스(α-나프틸)-N,N'-디페닐-4,4'-디아민(N,N'-bis(α-naphthyl)-N,N'-diphenyl-4,4'-diamine: NPB)을 넣고, 챔버 내의 진공도가 10-6torr에 도달할 때까지 배기시켰다. 그 후, 셀에 전류를 인가하여 NPB를 증발시켜 ITO 기판 상에 200Å 두께의 정공 주입층(3)을 증착하였다.Next, an ITO substrate was placed in a substrate folder of a vacuum deposition equipment, and N, N'-bis (α-naphthyl) -N, N'-diphenyl- (N, N'-bis (? -Naphthyl) -N, N'-diphenyl-4,4'-diamine: NPB) was added to the reactor and the reactor was evacuated until the degree of vacuum in the chamber reached 10 -6 torr. Thereafter, a current was applied to the cell to evaporate NPB to deposit a hole injection layer 3 having a thickness of 200 A on the ITO substrate.

Figure 112013070990148-pat00074
Figure 112013070990148-pat00074

이어서, 진공 증착 장비 내의 다른 셀에 하기 구조의 4,4',4"-트리스(N,N-(2-나프틸)-페닐아미노)트리페닐 아민(4,4',4"-tris(N,N-(2-naphthyl)-phenylamino)triphenyl amine: 2T-NATA)을 넣고, 셀에 전류를 인가하여 2-TNATA를 증발시켜 정공주입층 위에 600Å두께의 정공수송층(4)을 증착하였다.Then, 4,4 ', 4 "-tris (N, N- (2-naphthyl) -phenylamino) triphenylamine (4,4' 2-TNATA was evaporated by applying current to the cell to deposit a hole transport layer 4 having a thickness of 600 Å on the hole injection layer.

Figure 112013070990148-pat00075
Figure 112013070990148-pat00075

정공주입층, 정공수송층을 형성시킨 후, 그 위에 발광층을 다음과 같이 증착시켰다. 진공 증착 장비 내의 한쪽 셀에 발광 재료로 본 발명에 따른 화합물(예: 화합물 235)을 넣었다. 또 다른 셀에는 하기 구조를 가진 도펀트 1을 넣은 후, 두 셀을 같이 가열, 도펀트 1의 증착속도 비율을 5중량%로 증착함으로써 상기 정공수송층 상에 400Å(호스트: 도펀트= 95:5중량비) 두께의 발광층(5)을 증착하였다.A hole injecting layer and a hole transporting layer were formed, and then a light emitting layer was deposited thereon as follows. A compound according to the present invention (for example, Compound 235) was put into one cell in a vacuum vapor deposition apparatus as a light emitting material. Dopant 1 having the following structure was doped into another cell, and then the two cells were heated together to deposit the dopant 1 at a deposition rate of 5 wt%, thereby forming a 400 Å (host: dopant = 95: 5 weight ratio) thickness on the hole transport layer Emitting layer 5 was deposited.

<화합물 235> <Compound 235>

Figure 112013070990148-pat00076
Figure 112013070990148-pat00076

<도펀트 1><Dopant 1>

Figure 112013070990148-pat00077
Figure 112013070990148-pat00077

이어서, 전자수송층(6)으로서 하기 구조의 트리스(8-하이드록시퀴놀린)알루미늄(Ⅲ)(tris(8-hydroxyquinoline)aluminum(Ⅲ): Alq3)를 200Å 두께로 증착하였다. 그 후 전자주입층(7)으로 하기 구조의 화합물 리튬 플루오라이드(lithium fluoride: LiF)를 10Å 두께로 증착한 후, Al 음극(8)을 1,000Å의 두께로 증착하여 OLED를 제작하였다.Subsequently, tris (8-hydroxyquinoline) aluminum (III) (tris (8-hydroxyquinoline) aluminum (III): Alq3) having the following structure was vapor-deposited as the electron transport layer 6 to a thickness of 200 Å. Then, lithium fluoride (LiF) having the following structure was deposited as the electron injecting layer 7 to a thickness of 10 Å, and then an Al cathode 8 was deposited to a thickness of 1,000 Å to prepare an OLED.

Figure 112013070990148-pat00078
Figure 112013070990148-pat00078

OLED 제작에 필요한 모든 유기 화합물은 재료 별로 각각 10-6∼10-8torr 하에서 진공 승화 정제하여 OLED 제작에 사용하였다.All the organic compounds required for OLED fabrication were vacuum sublimated and purified at 10-6 to 10-8 torr for each material, and used for OLED fabrication.

<< 실시예Example 2> 본 발명의 화합물을 이용한  &Lt; 2 &gt; OLEDOLED 소자의 제작 Device fabrication

실시예 1과 동일한 방법으로 정공주입층, 정공수송층을 형성시킨 후, 상기 진공 증착 장비 내의 한쪽 셀에 발광 재료로 본 발명에 따른 화합물 235을 넣고, 또 다른 셀에는 하기 구조를 가진 도펀트 2를 넣은 후, 두 물질을 다른 속도로 증발시켜 호스트를 기준으로 5 중량%로 도핑함으로써, 상기 정공수송층 위에 400Å 두께의 발광층을 증착하였다.A hole injection layer and a hole transport layer were formed in the same manner as in Example 1, and Compound 235 according to the present invention was added as a light emitting material to one cell in the vacuum vapor deposition equipment, and dopant 2 having the following structure was added to another cell Then, the two materials were evaporated at different rates and doped with 5 wt% based on the host, thereby depositing a 400Å thick light emitting layer on the hole transport layer.

<도펀트 2><Dopant 2>

Figure 112013070990148-pat00079
Figure 112013070990148-pat00079

<실시예 3∼290> 본 발명의 화합물을 이용한 OLED 소자의 제작&Lt; Examples 3 to 290 > Production of OLED device using the compound of the present invention

하기 표 2에 기재한 호스트와 도펀트를 이용한 것을 제외하고는, 실시예 1과 동일한 방법으로 OLED를 제조하였다.An OLED was prepared in the same manner as in Example 1 except that the host and the dopant described in Table 2 were used.

<< 비교예Comparative Example 1∼4> 종래의 유기 발광 화합물을 이용한  1 to 4> Using conventional organic luminescent compounds OLEDOLED 의 제작Production

상기 실시예 1과 동일한 방법으로 정공주입층(3), 정공수송층(4)을 형성시켰다. 그 후, 상기 진공 증착 장비 내의 다른 셀에 발광 호스트 재료인 ADN(dinaphthylanthracene)의 이성질체 2가지(비교화합물 1, 2)를 사용하였으며, 또 다른 셀에는 실시예 1 과 같은 도펀트 1을 각각 넣은 후, 상기 정공수송층 위에 30㎚ 두께의 발광층(5)을 증착하였다.A hole injecting layer 3 and a hole transporting layer 4 were formed in the same manner as in Example 1 above. Thereafter, two isomers of dinaphthylthracene (ADN) (Comparative Compounds 1 and 2) were used as light emitting host materials in the other cells in the vacuum vapor deposition equipment, dopants 1 as in Example 1 were placed in another cell, A light emitting layer 5 with a thickness of 30 nm was deposited on the hole transporting layer.

<비교화합물 1> <비교화합물 2> &Lt; Comparative Compound 1 > < Comparative Compound 2 >

Figure 112013070990148-pat00080
Figure 112013070990148-pat00081
Figure 112013070990148-pat00080
Figure 112013070990148-pat00081

이어서, 실시예 1과 동일한 방법으로 전자수송층(6)과 전자주입층(7)을 증착한 후, 다른 진공 증착 장비를 이용하여 Al 음극(8)을 150㎚의 두께로 증착하여 OLED를 제작하였다.Subsequently, an electron transport layer 6 and an electron injection layer 7 were deposited in the same manner as in Example 1, and then an Al cathode 8 was vapor-deposited to a thickness of 150 nm using another vacuum vapor deposition apparatus to produce an OLED .

<< 실험예Experimental Example > > OLEDOLED 의 특성 평가Characterization of

OLED의 효율 및 특성을 평가하여 하기 표 2에 기재하였다. 효율은 cd/A에서 그리고, 수명은 효율이 50%까지 떨어질 때까지의 시간을 하기 표 2에 기재하였다.The efficiency and characteristics of the OLED were evaluated and are shown in Table 2 below. The time until the efficiency drops to cd / A and the lifetime drops to 50% is shown in Table 2 below.

Figure 112013070990148-pat00082
Figure 112013070990148-pat00083
Figure 112013070990148-pat00084
Figure 112013070990148-pat00085
Figure 112013070990148-pat00086
Figure 112013070990148-pat00087
Figure 112013070990148-pat00088
Figure 112013070990148-pat00082
Figure 112013070990148-pat00083
Figure 112013070990148-pat00084
Figure 112013070990148-pat00085
Figure 112013070990148-pat00086
Figure 112013070990148-pat00087
Figure 112013070990148-pat00088

Figure 112013070990148-pat00089
Figure 112013070990148-pat00090
Figure 112013070990148-pat00089
Figure 112013070990148-pat00090

Figure 112013070990148-pat00091
Figure 112013070990148-pat00091

Figure 112013070990148-pat00092
Figure 112013070990148-pat00092

Figure 112013070990148-pat00093

Figure 112013070990148-pat00093

상기 표 2을 참조하면, 본 발명의 화합물을 이용하여 제조된 소자가 비교예에 비해 효율, 수명 및 열적 안정성이 우수함을 알 수 있다.Referring to Table 2, it can be seen that the device manufactured using the compound of the present invention is superior in efficiency, lifetime and thermal stability as compared with the comparative example.

Claims (11)

하기 화학식 1로 표시되는 화합물:
Figure 112015047556074-pat00094

상기 화학식 1에서,
R1 내지 R6은 서로 같거나 다르고, 각각 독립적으로, 수소; 할로겐 원자; 아다만틸; 나이트로; 하이드록시; 시아노; 치환 또는 비치환된 (C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴; 치환 또는 비치환된 (C5-C60)헤테로아릴; N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬; 치환 또는 비치환된 (C3-C60)시클로알킬; 치환 또는 비치환된 트리(C1-C60)알킬실릴; 치환 또는 비치환된 디(C1-C60)알킬(C6-C60)아릴실릴; 치환 또는 비치환된 트리(C6-C60)아릴실릴; 치환 또는 비치환된 (C7-C60)바이시클로알킬; 치환 또는 비치환된 (C2-C60)알케닐; 치환 또는 비치환된 (C2-C60)알키닐; 치환 또는 비치환된 (C1-C60)알콕시; 치환 또는 비치환된 (C1-C60)알킬아미노; 치환 또는 비치환된 (C6-C60)아릴아미노; 치환 또는 비치환된 (C6-C60)아르(C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴옥시; 치환 또는 비치환된 (C6-C60)아릴티오; 치환 또는 비치환된 (C1-C60)알킬티오; 치환 또는 비치환된 (C1-C60)알콕시카보닐; 치환 또는 비치환된 (C1-C60)알킬카보닐; 또는 (C6-C60)아릴카보닐이며,
상기 R1 내지 R6는 인접하는 기와 서로 결합하여 지방족 고리, 방향족 고리, 헤테로 방향족 고리를 형성하거나, 치환 또는 비치환된 (C2-C60)알킬렌 또는 (C2-C60)알케닐렌으로 서로 연결하여 지방족 고리, 방향족 고리, 헤테로 방향족 고리를 형성하고,
Ar1은 1~5개의 고리를 갖는 치환 또는 비치환된 (C6-C60)의 방향족 화합물 또는 융합고리형 방향족 화합물이고,
A는 아다만틸; 나이트로; 하이드록시; 시아노; 치환 또는 비치환된 (C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴; 치환 또는 비치환된 (C2-C60)헤테로아릴; N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬; 치환 또는 비치환된 (C3-C60)시클로알킬; 치환 또는 비치환된 트리(C1-C60)알킬실릴; 치환 또는 비치환된 디(C1-C60)알킬(C6-C60)아릴실릴; 치환 또는 비치환된 트리(C6-C60)아릴실릴; 치환 또는 비치환된 (C7-C60)바이시클로알킬; 치환 또는 비치환된 (C2-C60)알케닐; 치환 또는 비치환된 (C2-C60)알키닐; 치환 또는 비치환된 (C1-C60)알콕시; 치환 또는 비치환된 (C1-C60)알킬아미노; 치환 또는 비치환된 (C6-C60)아릴아미노; 치환 또는 비치환된 (C6-C60)아르(C1-C60)알킬; 치환 또는 비치환된 (C6-C60)아릴옥시; 치환 또는 비치환된 (C6-C60)아릴티오; 치환 또는 비치환된 (C1-C60)알킬티오; 치환 또는 비치환된 (C1-C60)알콕시카보닐; 치환 또는 비치환된 (C1-C60)알킬카보닐; (C6-C60)아릴카보닐; 또는
Figure 112015047556074-pat00131
이되,
Ar3는 치환 또는 비치환된 (C1-C60)알킬렌옥시; 치환 또는 비치환된 (C1-C60)알킬렌티오; 치환 또는 비치환된 (C6-C60)아릴렌옥시; (C6-C60)아릴렌티오; 치환 또는 비치환된 (C6-C60)아릴렌; 또는 (C3-C60)헤테로아릴렌이고,
R7은 R1 내지 R6의 기재와 동일하고,
n은 1이고,
X는 -O-, -Si(-R21)(-R22)-, -N(-R21)- 또는 -C(-R21)(-R22)-로서,
이때, R21 및 R22는 각각 독립적으로 수소; 직쇄상 또는 분지상의 (C1-C60)알킬; 메톡시로 치환 또는 비치환된 (C6-C60)아릴; 페닐기로 치환 또는 비치환된 (C6-C60)헤테로아릴; (C6-C60)알콕시아릴; (C1-C60)알킬티오(C6-C60)아릴; 아미노(C6-C60)아릴; 또는 (C1-C60)알킬실릴(C6-C60)아릴이고,
상기 R1 내지 R6, Ar1, A 및 Ar3에서의 치환은 서로 같거나 다르고 각각 독립적으로, 할로겐, (C1-C60)알킬, (C6-C60)아릴, (C2-C60)헤테로아릴, N, O, S 및 Si로부터 선택된 1종 또는 2종 이상을 포함하는 5원 또는 6원의 헤테로시클로알킬, (C3-C60)시클로알킬, 트리(C1-C60)알킬실릴, 디(C1-C60)알킬(C6-C60)아릴실릴, 트리(C6-C60)아릴실릴, 아다만틸, (C7-C60)바이시클로알킬, (C2-C60)알케닐, (C2-C60)알키닐, (C1-C60)알콕시, 시아노, (C1-C60)알킬아미노, (C6-C60)아릴아미노, (C6-C60)아르(C1-C60)알킬, (C6-C60)아릴옥시, (C1-C60)알킬티오, (C6-C60)아릴티오, (C1-C60)알콕시카보닐, (C1-C60)알킬카보닐, (C6-C60)아릴카보닐, 카복실산, 나이트로, 하이드록시 또는 트리플루오로메틸로 치환 또는 비치환된 것을 의미한다.
A compound represented by the following formula (1):
Figure 112015047556074-pat00094

In Formula 1,
R 1 to R 6 are the same or different from each other and each independently hydrogen; A halogen atom; Adamantyl; Nitro; Hydroxy; Cyano; Substituted or unsubstituted (C 1 -C 60 ) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryl; Substituted or unsubstituted (C 5 -C 60) heteroaryl; 5 or 6-membered heterocycloalkyl containing one or more heteroatoms selected from N, O, S and Si; Substituted or unsubstituted (C 3 -C 60 ) cycloalkyl; A substituted or unsubstituted tree (C 1 -C 60) alkylsilyl; A substituted or unsubstituted di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl; A substituted or unsubstituted tree (C 6 -C 60) arylsilyl; Substituted or unsubstituted (C 7 -C 60) bicycloalkyl-alkyl; Substituted or unsubstituted (C 2 -C 60 ) alkenyl; Substituted or unsubstituted (C 2 -C 60) alkynyl; Substituted or unsubstituted (C 1 -C 60) alkoxy; Substituted or unsubstituted (C 1 -C 60 ) alkylamino; Substituted or unsubstituted (C 6 -C 60 ) arylamino; Substituted or unsubstituted (C 6 -C 60) aralkyl (C 1 -C 60) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryloxy; Substituted or unsubstituted (C 6 -C 60 ) arylthio; A substituted or unsubstituted (C 1 -C 60) alkylthio; Substituted or unsubstituted (C 1 -C 60 ) alkoxycarbonyl; Substituted or unsubstituted (C 1 -C 60) alkylcarbonyl; Or (C 6 -C 60) aryl-carbonyl,
Wherein R 1 to R 6 are bonded to adjacent groups to form an aliphatic ring, an aromatic ring, a heteroaromatic ring, or a substituted or unsubstituted (C 2 -C 60 ) alkylene or (C 2 -C 60 ) alkenylene To form an aliphatic ring, an aromatic ring, a heteroaromatic ring,
Ar 1 is a substituted or unsubstituted (C 6 -C 60 ) aromatic compound or fused ring aromatic compound having 1 to 5 rings,
A is adamantyl; Nitro; Hydroxy; Cyano; Substituted or unsubstituted (C 1 -C 60 ) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryl; Substituted or unsubstituted (C 2 -C 60 ) heteroaryl; 5 or 6-membered heterocycloalkyl containing one or more heteroatoms selected from N, O, S and Si; Substituted or unsubstituted (C 3 -C 60 ) cycloalkyl; A substituted or unsubstituted tree (C 1 -C 60) alkylsilyl; A substituted or unsubstituted di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl; A substituted or unsubstituted tree (C 6 -C 60) arylsilyl; Substituted or unsubstituted (C 7 -C 60) bicycloalkyl-alkyl; Substituted or unsubstituted (C 2 -C 60 ) alkenyl; Substituted or unsubstituted (C 2 -C 60 ) alkynyl; Substituted or unsubstituted (C 1 -C 60) alkoxy; Substituted or unsubstituted (C 1 -C 60 ) alkylamino; Substituted or unsubstituted (C 6 -C 60 ) arylamino; Substituted or unsubstituted (C 6 -C 60) aralkyl (C 1 -C 60) alkyl; Substituted or unsubstituted (C 6 -C 60 ) aryloxy; Substituted or unsubstituted (C 6 -C 60 ) arylthio; A substituted or unsubstituted (C 1 -C 60) alkylthio; Substituted or unsubstituted (C 1 -C 60 ) alkoxycarbonyl; Substituted or unsubstituted (C 1 -C 60) alkylcarbonyl; (C 6 -C 60 ) arylcarbonyl; or
Figure 112015047556074-pat00131
However,
Ar 3 is substituted or unsubstituted (C 1 -C 60 ) alkyleneoxy; Substituted or unsubstituted (C 1 -C 60) alkylene-thio; Substituted or unsubstituted (C 6 -C 60 ) aryleneoxy; (C 6 -C 60 ) arylene thio; Substituted or unsubstituted (C 6 -C 60 ) arylene; Or (C 3 -C 60) and heteroarylene,
R 7 is the same as the description of R 1 to R 6 ,
n is 1,
X is -O-, -Si (-R 21) ( - R 22) -, -N (-R 21) - or -C (-R 21) (- R 22) - a,
Wherein R 21 and R 22 are each independently selected from the group consisting of hydrogen; Straight or branched (C 1 -C 60) alkyl; (C 6 -C 60 ) aryl, unsubstituted or substituted with methoxy; (C 6 -C 60 ) heteroaryl substituted or unsubstituted with a phenyl group; (C 6 -C 60 ) alkoxyaryl; (C 1 -C 60) alkylthio (C 6 -C 60) aryl; Amino (C 6 -C 60 ) aryl; Or (C 1 -C 60) alkyl silyl (C 6 -C 60) aryl,
Wherein R 1 to R 6, Ar 1, A, and Ar 3 is substituted at the same or different and independently selected from, halogen, (C 1 -C 60) alkyl, (C 6 -C 60) each aryl, (C 2 - C 60) heteroaryl, N, O, 5-or 6-membered heterocycloalkyl of, containing one or two or more selected from S and Si (C 3 -C 60) cycloalkyl, tri (C 1 -C 60) alkylsilyl, di (C 1 -C 60) alkyl (C 6 -C 60) arylsilyl, tri (C 6 -C 60) arylsilyl, adamantyl, (C 7 -C 60) alkyl, bicycloalkyl, (C 2 -C 60) alkenyl, (C 2 -C 60) alkynyl, (C 1 -C 60) alkoxy, cyano, (C 1 -C 60) alkylamino, (C 6 -C 60) aryl amino, (C 6 -C 60) aralkyl (C 1 -C 60) alkyl, (C 6 -C 60) aryloxy, (C 1 -C 60) alkylthio, (C 6 -C 60) arylthio, ( C 1 -C 60) alkoxycarbonyl, (C 1 -C 60) alkylcarbonyl, (C 6 -C 60) arylcarbonyl, carboxylic acid, substituted or unsubstituted nitro, methyl by hydroxy or trifluoromethyl .
제1항에 있어서, 상기 화학식 1로 표시되는 화합물이 하기 화학식 1A로 표시되는 화합물인 것을 특징으로 하는 상기 화합물:
Figure 112015047556074-pat00096

상기 화학식 1A에 있어서,
A는 치환 또는 비치환된 (C6-C60)아릴; 또는 치환 또는 비치환된 (C2-C60)헤테로 아릴이고,
R1은 수소; 치환 또는 비치환된 (C6-C60)아릴; 또는 치환 또는 비치환된 (C5-C60)헤테로아릴이고,
R2 내지 R6는 수소이고,
n은 1이고,
X는 -N(-R21)- 또는 -C(-R21)(-R22)-이고,
R21 및 R22는 각각 독립적으로 직쇄상 또는 분지상의 (C1-C60)알킬; 메톡시로 치환 또는 비치환된 (C6-C60)아릴; 또는 페닐기로 치환 또는 비치환된 (C6-C60)헤테로아릴이고,
R17 내지 R20은 인접하는 기끼리 서로 결합하여 1종 또는 2종 이상의 방향족 또는 지방족 환을 형성한다.
The compound according to claim 1, wherein the compound represented by Formula 1 is a compound represented by Formula 1A:
Figure 112015047556074-pat00096

In the above formula (1A)
A is substituted or unsubstituted (C 6 -C 60 ) aryl; Or substituted or unsubstituted (C 2 -C 60 ) heteroaryl,
R 1 is hydrogen; Substituted or unsubstituted (C 6 -C 60 ) aryl; Or substituted or unsubstituted (C 5 -C 60) heteroaryl,
R 2 to R 6 are hydrogen,
n is 1,
X is -N (-R 21 ) - or -C (-R 21 ) (-R 22 ) -,
R 21 and R 22 are each independently a straight or branched (C 1 -C 60 ) alkyl; (C 6 -C 60 ) aryl, unsubstituted or substituted with methoxy; Or a heteroaryl group unsubstituted or substituted with a phenyl group (C 6 -C 60),
The adjacent groups of R 17 to R 20 are bonded to each other to form one or more aromatic or aliphatic rings.
제1항에 있어서, 상기 화학식 1로 표시되는 화합물이 하기 화학식 3, 화학식 4, 화학식 6, 화학식 7, 화학식 9, 화학식 10, 화학식 12 및 화학식 13으로 표시되는 화합물 군에서 선택되는 어느 하나인 것을 특징으로 하는 상기 화합물:
<화학식 3> <화학식 4>
Figure 112015047556074-pat00098
Figure 112015047556074-pat00099

<화학식 6> <화학식 7>
Figure 112015047556074-pat00101
Figure 112015047556074-pat00102

<화학식 9> <화학식 10>
Figure 112015047556074-pat00104
Figure 112015047556074-pat00105

<화학식 12> <화학식 13>
Figure 112015047556074-pat00107
Figure 112015047556074-pat00108

상기 화학식 3, 화학식 4, 화학식 6, 화학식 7, 화학식 9, 화학식 10, 화학식 12 및 화학식 13에 있어서,
A, R1 내지 R6은 제 1항의 화학식 1에서 정의한 바와 같고,
R9 내지 R16은 각각 독립적으로, R1 내지 R6의 기재와 동일하며,
R21 및 R22는 각각 독립적으로 수소; 직쇄상 또는 분지상의 (C1~C60)알킬; 메톡시로 치환 또는 비치환된 (C6-C60)아릴; 페닐기로 치환 또는 비치환된 (C6-C60)헤테로아릴; (C6-C60)알콕시아릴; (C1~C60)알킬티오(C6-C60)아릴; 아미노(C6-C60)아릴; 또는 (C1~C60)알킬실릴(C6-C60)아릴이다.
The compound according to claim 1, wherein the compound represented by Formula 1 is any one selected from the group consisting of compounds represented by Chemical Formulas 3, 4, 6, 7, 9, 10, 12, Wherein said compound:
&Lt; Formula 3 >< Formula 4 >
Figure 112015047556074-pat00098
Figure 112015047556074-pat00099

&Lt; Formula 6 >< EMI ID =
Figure 112015047556074-pat00101
Figure 112015047556074-pat00102

&Lt; Formula 9 &gt;&lt; EMI ID =
Figure 112015047556074-pat00104
Figure 112015047556074-pat00105

&Lt; Formula 12 >< EMI ID =
Figure 112015047556074-pat00107
Figure 112015047556074-pat00108

In Formula 3, Formula 4, Formula 6, Formula 7, Formula 9, Formula 10, Formula 12 and Formula 13,
A, R 1 to R 6 are the same as defined in the formula (1)
R 9 to R 16 are each independently the same as those of R 1 to R 6 ,
R 21 and R 22 are each independently hydrogen; Straight or branched (C 1 -C 60 ) alkyl; (C 6 -C 60 ) aryl, unsubstituted or substituted with methoxy; (C 6 -C 60 ) heteroaryl substituted or unsubstituted with a phenyl group; (C 6 -C 60 ) alkoxyaryl; (C 1 ~ C 60) alkylthio (C 6 -C 60) aryl; Amino (C 6 -C 60 ) aryl; Or (C 1 ~ C 60) alkyl silyl (C 6 -C 60) aryl.
제1항에 있어서, 상기 화학식 1로 표시되는 화합물이 하기의 구조식으로 표시되는 화합물 중 어느 하나인 것을 특징으로 하는 상기 화합물:
Figure 112015047556074-pat00109

Figure 112015047556074-pat00110

Figure 112015047556074-pat00132

Figure 112015047556074-pat00133

Figure 112015047556074-pat00113

Figure 112015047556074-pat00114

Figure 112015047556074-pat00115

Figure 112015047556074-pat00134

Figure 112015047556074-pat00135

Figure 112015047556074-pat00136

Figure 112015047556074-pat00137

Figure 112015047556074-pat00121

Figure 112015047556074-pat00122

Figure 112015047556074-pat00123

Figure 112015047556074-pat00124

Figure 112015047556074-pat00125

Figure 112015047556074-pat00126

Figure 112015047556074-pat00127
The compound according to claim 1, wherein the compound represented by the formula (1) is any one of compounds represented by the following structural formulas:
Figure 112015047556074-pat00109

Figure 112015047556074-pat00110

Figure 112015047556074-pat00132

Figure 112015047556074-pat00133

Figure 112015047556074-pat00113

Figure 112015047556074-pat00114

Figure 112015047556074-pat00115

Figure 112015047556074-pat00134

Figure 112015047556074-pat00135

Figure 112015047556074-pat00136

Figure 112015047556074-pat00137

Figure 112015047556074-pat00121

Figure 112015047556074-pat00122

Figure 112015047556074-pat00123

Figure 112015047556074-pat00124

Figure 112015047556074-pat00125

Figure 112015047556074-pat00126

Figure 112015047556074-pat00127
제 1 전극; 제 2 전극; 및 상기 제 1 전극과 제 2 전극 사이에 위치하고, 제1항의 화학식 1로 표시되는 화합물을 포함하는 유기막을 포함하는 유기전계발광소자.A first electrode; A second electrode; And an organic layer disposed between the first electrode and the second electrode, the organic layer including a compound represented by the general formula (1). 제5항에 있어서, 상기 유기막이 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층으로 이루어진 군으로부터 선택되는 1종 또는 2종 이상인 것을 특징으로 하는 상기 유기전계발광소자.The organic electroluminescent device according to claim 5, wherein the organic layer is one or more selected from the group consisting of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer. 제5항에 있어서, 상기 유기막이 정공주입층, 정공수송층 및 발광층으로 이루어진 군으로부터 선택되는 1종 또는 2종 이상인 것을 특징으로 하는 상기 유기전계발광소자.The organic electroluminescent device according to claim 5, wherein the organic layer is one or more selected from the group consisting of a hole injection layer, a hole transport layer and a light emitting layer. 삭제delete 제5항에 있어서, 상기 유기막이 아릴아민 화합물, 스티릴아릴아민 화합물 및 이들의 혼합물로 이루어진 군에서 선택되는 1종을 더 포함하는 것을 특징으로 하는 상기 유기전계발광소자.The organic electroluminescent device according to claim 5, wherein the organic layer further comprises one selected from the group consisting of an arylamine compound, a styrylarylamine compound, and a mixture thereof. 제5항 내지 제7항, 제9항 중 어느 한 항에 있어서, 상기 유기막이 1족, 2족, 4주기, 5주기 전이금속, 란탄계열금속 및 d-전이원소의 유기금속으로 이루어진 군으로부터 선택되는 1종 또는 2종 이상을 더 포함하는 것을 특징으로 하는 상기 유기전계발광소자.10. The organic electroluminescent device according to any one of claims 5 to 7 and 9, wherein the organic film is formed from a group consisting of organic metals of group 1, group 2, group 4, group 5 transition metal, lanthanide series and d- Wherein the organic electroluminescent device further comprises at least one selected from the group consisting of the organic electroluminescent device and the organic electroluminescent device. 제 1 전극; 제 2 전극; 및 상기 제 1 전극과 제 2 전극 사이에 위치하고 제1항의 화학식 1로 표시되는 화합물을 포함하는 유기막을 포함하는 유기태양전지.A first electrode; A second electrode; And an organic layer disposed between the first electrode and the second electrode and including a compound represented by the general formula (1).
KR1020130092850A 2012-08-09 2013-08-06 Novel compounds, organic light emitting device display and organic solar battery using the same KR101574704B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20120087502 2012-08-09
KR1020120087502 2012-08-09

Publications (2)

Publication Number Publication Date
KR20140021969A KR20140021969A (en) 2014-02-21
KR101574704B1 true KR101574704B1 (en) 2015-12-07

Family

ID=50268167

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130092850A KR101574704B1 (en) 2012-08-09 2013-08-06 Novel compounds, organic light emitting device display and organic solar battery using the same

Country Status (1)

Country Link
KR (1) KR101574704B1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6018098B2 (en) * 2014-01-24 2016-11-02 ▲いく▼▲雷▼光電科技股▲分▼有限公司 Electron transport compound and organic electroluminescent device using the compound
KR101508145B1 (en) * 2014-05-08 2015-04-07 성균관대학교산학협력단 Organic electroluminescent compound, producing method of the same and organic electroluminescent device including the same
CN105272961B (en) * 2014-06-06 2018-06-01 昱镭光电科技股份有限公司 Electron transport compound and the organic electroluminescent device using the compound
WO2017073933A1 (en) * 2015-10-26 2017-05-04 주식회사 엘지화학 Spiro-type compound and organic light emitting element comprising same
KR102000177B1 (en) 2015-10-26 2019-07-16 주식회사 엘지화학 Compound having spiro structure and organic light emitting device comprising the same
KR101981245B1 (en) * 2015-10-27 2019-05-22 주식회사 엘지화학 Cyclic compound and organic light emitting device comprising the same
KR102000171B1 (en) 2015-10-28 2019-07-16 주식회사 엘지화학 Compound having spiro structure and organic light emitting device comprising the same
CN105669527A (en) * 2016-01-07 2016-06-15 中节能万润股份有限公司 Small molecular organic electroluminescent material and application thereof
KR102642200B1 (en) * 2016-01-25 2024-03-05 삼성디스플레이 주식회사 An organic light emitting device
JP6700825B2 (en) * 2016-02-09 2020-05-27 キヤノン株式会社 Organic photoelectric conversion element, optical area sensor, imaging element, and imaging device
KR102044057B1 (en) 2016-04-28 2019-11-12 주식회사 엘지화학 Organic light emitting device
KR102120517B1 (en) * 2016-04-28 2020-06-08 주식회사 엘지화학 Organic light emitting device
CN110903158A (en) * 2018-09-18 2020-03-24 上海和辉光电有限公司 Organic luminescent material containing anthracene derivative, preparation method thereof and electroluminescent device
KR102303746B1 (en) * 2018-10-05 2021-09-17 주식회사 엘지화학 Novel compound and organic light emitting device comprising the same
CN110452210A (en) * 2019-08-27 2019-11-15 镇江博润新材料有限公司 A kind of condensed ring class Blue-light emitting host material, its application and the preparation of application device
CN112062775B (en) * 2020-09-18 2021-08-17 中节能万润股份有限公司 Organic electroluminescent material and preparation method and application thereof
JP2024046920A (en) * 2022-09-26 2024-04-05 キヤノン株式会社 Organic light-emitting device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010138121A (en) 2008-12-12 2010-06-24 Canon Inc Triazine compound, and organic light emitting element employing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010138121A (en) 2008-12-12 2010-06-24 Canon Inc Triazine compound, and organic light emitting element employing the same

Also Published As

Publication number Publication date
KR20140021969A (en) 2014-02-21

Similar Documents

Publication Publication Date Title
KR101574704B1 (en) Novel compounds, organic light emitting device display and organic solar battery using the same
JP5710491B2 (en) Novel organic light-emitting compound and organic light-emitting device using the same
JP5797672B2 (en) Novel organic electroluminescent compound and organic electroluminescent device using the same
KR101412246B1 (en) New compounds and organic electronic device using the same
KR101771531B1 (en) Spiro compound and organic electroluminescent devices comprising the same
KR101792175B1 (en) Spiro compound and organic electroluminescent devices comprising the same
JP2015120692A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
JP2010013444A (en) New organic electroluminescent compound and organic electroluminescent device comprising the same
KR20090098585A (en) Organic electroluminescent device using the organic electroluminescent compounds
JP2009249378A (en) New organic electroluminescent compound, and organic electroluminescent element using the same
JP2010059158A (en) New organic electroluminescent compound and organic electroluminescent device produced by using the same
KR20120038060A (en) Novel compounds for organic electronic material and organic electroluminescent device using the same
KR20110008784A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR101262420B1 (en) New anthracene derivatives and organic electronic devices using the same
JP2015159288A (en) Electroluminescence element adopting electroluminescent compound as light-emitting material
KR20100109293A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
JP2009132706A (en) New organic electroluminescent compound and organic electroluminescent device using the same
KR101597865B1 (en) New compounds and organic electronic device using the same
KR20140076888A (en) aromatic compound having fused cyclic substituent in aromatic ring and organic light-emitting diode including the same
KR20100106026A (en) Electroluminescent device using the electroluminescent compounds
JP2009149607A (en) Novel organic electroluminescent compound and organic electroluminescent device using the same
KR20110088118A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20130100948A (en) New anthracene derivatives and organic electronic device using the same
KR20100118258A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20080016007A (en) New anthracene derivatives and organic electronic device using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
FPAY Annual fee payment

Payment date: 20181129

Year of fee payment: 4